var title_f13_61_14288="EUS insulinoma";
var content_f13_61_14288=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endosonographic image of an insulinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endosonographic image of an insulinoma detected in a woman with recurrent episodes of hypoglycemia showing a well demarcated, homogenous hypoechoic mass lesion in the head of the pancreas adjacent to the common bile duct (CBD, above) and portal vein (PV, below) without invasion of these structures. The lesion had not been detected with other imaging modalities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Maryam Moini, MD, and Seyed Alireza Taghavi, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14288=[""].join("\n");
var outline_f13_61_14288=null;
var title_f13_61_14289="Anhidrotic ectodermal dysplasia";
var content_f13_61_14289=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anhidrotic ectodermal dysplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sparse hair is evident in this patient with anhidrotic ectodermal dysplasia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14289=[""].join("\n");
var outline_f13_61_14289=null;
var title_f13_61_14290="Blood supply hip";
var content_f13_61_14290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F54405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F54405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arterial blood supply of the proximal femur",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arterial supply of the proximal femur. The capital femoral epiphysis and physis are supplied by the medial circumflex artery through two retinacular systems: the posterosuperior and posteroinferior. The lateral circumflex artery supplies the greater trochanter and the lateral portion of the proximal femoral physis and a small area of the anteromedial metaphysis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: McCarthy J, Noonan K. Fractures and traumatic dislocations of the hip in children. In: Rockwood and Wilkins' Fractures in Children, 7th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14290=[""].join("\n");
var outline_f13_61_14290=null;
var title_f13_61_14291="CDC weight for age boys 2 to 20 years";
var content_f13_61_14291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 586px\">",
"   <div class=\"ttl\">",
"    Weight-for-age percentiles, boys, 2 to 20 years, CDC growth charts: United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 566px; height: 688px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: National Health Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion (2000).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14291=[""].join("\n");
var outline_f13_61_14291=null;
var title_f13_61_14292="Mepenzolate: Patient drug information";
var content_f13_61_14292=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mepenzolate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/39/9844?source=see_link\">",
"     see \"Mepenzolate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F192695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cantil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F192696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cantil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691855",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat GI (gastrointestinal) ulcers.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mepenzolate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701043",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to tartrazine, talk with your doctor. Some products have tartrazine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703352",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bowel block, enlarged colon, glaucoma, a fast heartbeat, heart disease, myasthenia gravis, slow-moving GI (gastrointestinal) tract, trouble passing urine, or very bad ulcerative colitis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man with problems passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10837 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6F9A708CB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14292=[""].join("\n");
var outline_f13_61_14292=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192695\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192696\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014898\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014897\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014902\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014903\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014905\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014900\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014901\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014906\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014907\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/39/9844?source=related_link\">",
"      Mepenzolate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_61_14293="Systemic treatment of advanced cutaneous squamous and basal cell carcinomas";
var content_f13_61_14293=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic treatment of advanced cutaneous squamous and basal cell carcinomas",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14293/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14293/contributors\">",
"     Renato G Martins, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14293/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14293/contributors\">",
"     Robert S Stern, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14293/contributors\">",
"     June K Robinson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14293/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14293/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/61/14293/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basal cell carcinoma and squamous cell carcinoma of the skin, together referred to as nonmelanoma skin cancer, are the most commonly diagnosed malignant neoplasms in the white population of the United States. Because many patients are treated as outpatients in an office setting, reliable statistics are difficult to obtain. Nonetheless, the National Cancer Institute estimates that approximately one million new cases occurred in 2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The vast majority of patients can be successfully managed with a variety of simple procedures, such as cryotherapy, curettage and electrodesiccation, topical treatments (5-fluorouracil,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    ), or simple surgical excision. When lesions are more advanced, Mohs micrographic surgery, more extensive surgical resection, or radiation therapy generally are generally sufficient to control locoregional disease.",
"   </p>",
"   <p>",
"    Despite their high prevalence, these skin cancers are only rarely fatal. It is estimated that in 2007, approximately 1000 patients died of the disease. Squamous cell carcinomas are biologically more aggressive, and neglected lesions can be life threatening both due to local extension or metastasis. In contrast, basal cell carcinoma is only very rarely life threatening.",
"   </p>",
"   <p>",
"    The use of systemic therapy is limited to patients with distant metastases or locally advanced disease that cannot be adequately managed with surgical or radiotherapeutic techniques.",
"   </p>",
"   <p>",
"    Systemic chemotherapy for basal cell and squamous cancers of the skin is discussed here. The treatment of localized basal cell and squamous cell carcinomas are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link\">",
"     \"Treatment and prognosis of basal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=see_link\">",
"     \"Treatment of basal cell carcinomas at high risk for recurrence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TNM STAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A TNM staging system has been developed for classification of patients with advanced cutaneous squamous cell carcinoma and is supported by both the American Joint Committee on Cancer (AJCC) and the International Union for Cancer Control (UICC) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/2\">",
"     2",
"    </a>",
"    ]. This system is presented in the following table (",
"    <a class=\"graphic graphic_table graphicRef78140 \" href=\"UTD.htm?5/0/5134\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TARGETED THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Targeted therapies are being developed for a range of malignancies, based upon an understanding of the underlying molecular pathogenesis. This approach has led to the development of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/59/18357?source=see_link\">",
"     vismodegib",
"    </a>",
"    , an inhibitor of the hedgehog signaling pathway, for basal cell carcinomas and these may eventually lead to the development of other agents for patients with advanced or metastatic skin cancers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Vismodegib",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hedgehog signaling pathway can cause basal cell proliferation and tumor growth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/3\">",
"     3",
"    </a>",
"    ]. Signaling in this pathway is initiated by the cell surface receptor smoothened homolog (SMO). In adults this pathway normally is inhibited by another cell surface receptor, the patched homolog 1 (PTCH1). Binding of the hedgehog ligand to PTCH1 prevents this inhibition.",
"   </p>",
"   <p>",
"    Two mechanisms have been identified by which the hedgehog pathway may be involved in the pathogenesis of basal cell carcinoma. Mutations of PTCH1 may prevent inhibition of SMO activation of the hedgehog pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Alternatively, mutations of SMO may result in constitutive activation of the pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=see_link&amp;anchor=H3#H3\">",
"     \"Nevoid basal cell carcinoma syndrome\", section on 'Molecular pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/59/18357?source=see_link\">",
"     Vismodegib",
"    </a>",
"    (150 mg as a single oral daily dose) is an oral small molecule inhibitor of SMO, which thus blocks activation of the hedgehog pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/59/18357?source=see_link\">",
"     vismodegib",
"    </a>",
"    was demonstrated in a multicenter, nonrandomized study that included 33 patients with metastatic basal cell carcinoma and 63 patients with locally advanced disease that was not amenable to surgery or radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/9\">",
"     9",
"    </a>",
"    ]. The response rate (RR) in patients with metastatic disease was 30 percent and they were all partial. Patients with locally advanced disease had an overall 43 percent response rate and a 21 percent complete response rate. Ten of the 13 patients with a complete response had no evidence of progression as of the study data-cutoff point. The waterfall plots indicate that a large majority of patients had some tumor shrinkage as the best response. The median duration of response of 7.6 months and the median progression-free survival was 9.5 months in both groups.",
"   </p>",
"   <p>",
"    Overall, adverse events occurring in more than 30 percent of patients included muscle spasms, alopecia, taste abnormalities (dysgeusia and ageusia), and fatigue. Grade 3 or 4 side effects were rare and occurred in no more than 5 percent of patients. However there is indirect evidence that grades 1 and 2 toxicities had a significant impact in the quality of life of patients; the most common reason to stop therapy in the locally advanced group was not disease progression but rather patient&rsquo;s decision (25 percent).",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/59/18357?source=see_link\">",
"     Vismodegib",
"    </a>",
"    may also have a role in the management of patients with nevoid basal cell carcinoma syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=see_link&amp;anchor=H32#H32\">",
"     \"Nevoid basal cell carcinoma syndrome\", section on 'Future directions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1587553565\">",
"    <span class=\"h2\">",
"     EGFR pathway",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     Cetuximab",
"    </a>",
"    , a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), has antitumor activity in patients with advanced squamous cell carcinoma of the skin, as initially suggested by case reports (",
"    <a class=\"graphic graphic_picture graphicRef77608 \" href=\"UTD.htm?22/9/22679\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential role of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    in treating advanced squamous cell carcinoma of the skin was studied prospectively in a phase II study that included 36 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/13\">",
"     13",
"    </a>",
"    ]. The majority of patients had local-regional disease and only 8 percent had systemic metastases. Cetuximab was administered on its conventional weekly schedule (400",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    on week 1 and then 250",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    weekly). Eight partial and two complete responses were observed (objective response rate 28 percent in the intention to treat population), and 15 had stable disease for an overall disease control rate of 69 percent. Three patients were able to undergo complete resection of their tumor following treatment with cetuximab. The most common grade 3 and 4 toxicities included infection and tumor bleeding (eight and four cases, respectively). In line with what is observed in other malignancies, patients developing acneiform rash had a longer progression-free survival and a tendency for a longer survival (8.9 versus 4 months; p=.054).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175770610\">",
"    <span class=\"h1\">",
"     SYSTEMIC CHEMOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the rarity of metastatic basal cell and squamous cell cancers of the skin, the approach to systemic treatment is based primarily upon isolated case reports, with only a few small case series. In the published experience,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    -based combinations appear to be the most active regimens. These regimens were in general adapted from those used for squamous cell cancers arising in other sites.",
"   </p>",
"   <p>",
"    The potential role of systemic chemotherapy is illustrated by three of the largest reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A combination of bolus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      , plus a five-day infusion of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      and 5-fluorouracil, was used to treat 14 patients with advanced squamous cell carcinoma of the skin or lip [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/14\">",
"       14",
"      </a>",
"      ]. Objective tumor responses (four complete and seven partial) were observed in 11 patients. In seven patients, tumor regression with systemic chemotherapy permitted subsequent definitive local treatment with either surgery or radiation therapy.",
"     </li>",
"     <li>",
"      A case report of one patient with basal cell carcinoma metastatic to the lungs observed a complete response with a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/15\">",
"       15",
"      </a>",
"      ]. The authors also reviewed the literature and found 12 other patients with metastatic basal cell carcinoma who were treated with platinum-containing regimens. Among these 12, five had a complete response and four had a partial response.",
"     </li>",
"     <li>",
"      In another report, five patients with locally advanced disease (three squamous cell and two basal cell) were treated with a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      daily times four plus a four day continuous infusion of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/16\">",
"       16",
"      </a>",
"      ]. Four patients had an objective response (one complete) and one patient had disease progression.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although squamous cell and basal cell carcinomas are sensitive to platinum-based chemotherapy, the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    requires adequate kidney function. In addition, cytotoxic chemotherapy can be associated with significant bone marrow toxicity. Patients with these skin cancers often are elderly and have significant comorbidities, which make then unable to tolerate the toxicities associated with these regimens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/42/10922?source=see_link\">",
"     \"Systemic chemotherapy for cancer in elderly persons\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ALLOGENIC ORGAN TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immunosuppression required after allogenic organ transplantation increases the risk of various skin cancers. In this setting, squamous cell carcinoma is more common than basal cell cancer, in contrast to the distribution of skin cancers in the nontransplant population. The squamous cell and basal cell carcinomas that arise in this setting are more aggressive and are more likely to recur after resection.",
"   </p>",
"   <p>",
"    The development of skin cancer in patients with chronic immunosuppression following organ transplantation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link&amp;anchor=H4#H4\">",
"     \"Development of malignancy following solid organ transplantation\", section on 'Skin cancers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No specific recommendations for treatment of advanced skin cancer in patients can be made for patients on chronic immunosuppression. At least one report has suggested that a decrease in the level of immunosuppression may slow the development and progression of skin cancers in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14293/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cutaneous squamous and basal cell carcinomas are the most common malignancy in the white population in the United States. In the overwhelming majority of cases, locoregional therapy is curative and systemic therapy is not indicated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link\">",
"       \"Treatment and prognosis of basal cell carcinoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=see_link\">",
"       \"Treatment of basal cell carcinomas at high risk for recurrence\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link\">",
"       \"Treatment and prognosis of cutaneous squamous cell carcinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with metastatic or locally advanced basal cell carcinoma that is not amenable to treatment with surgery or radiation therapy, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/59/18357?source=see_link\">",
"       vismodegib",
"      </a>",
"      , an inhibitor of sonic hedgehog pathway (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Vismodegib'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In a phase II study, single agent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      showed substantial evidence of activity in patients with locally advanced or metastatic disease. In addition, platinum-based chemotherapy regimens have had activity in case reports. Although no randomized data exists, cetuximab seems to be a reasonable alternative to conventional chemotherapy. In selected cases, antitumor activity with either of these approaches has permitted subsequent surgical or radiotherapeutic management of locally advanced disease, or provided meaningful palliation. (See",
"      <a class=\"local\" href=\"#H1587553565\">",
"       'EGFR pathway'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     www.cancer.gov/cancertopics/types/skin (Accessed on April 11, 2011).",
"    </li>",
"    <li>",
"     Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: American Joint Committee on Cancer Staging Manual, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2009. p.301.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/3\">",
"      Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/4\">",
"      Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/5\">",
"      Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272:1668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/6\">",
"      Xie J, Murone M, Luoh SM, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998; 391:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/7\">",
"      Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/8\">",
"      LoRusso PM, Rudin CM, Reddy JC, et al. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res 2011; 17:2502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/9\">",
"      Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366:2171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/10\">",
"      Bauman JE, Eaton KD, Martins RG. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab. Arch Dermatol 2007; 143:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/11\">",
"      Suen JK, Bressler L, Shord SS, et al. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab. Anticancer Drugs 2007; 18:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/12\">",
"      Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology 2009; 219:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/13\">",
"      Maubec E, Petrow P, Scheer-Senyarich I, et al. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 2011; 29:3419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/14\">",
"      Sadek H, Azli N, Wendling JL, et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer 1990; 66:1692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/15\">",
"      Carneiro BA, Watkin WG, Mehta UK, Brockstein BE. Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest 2006; 24:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/16\">",
"      Denic S. Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin. Am J Clin Oncol 1999; 22:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14293/abstract/17\">",
"      Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137:459.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7619 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-AD134220F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14293=[""].join("\n");
var outline_f13_61_14293=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TNM STAGE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TARGETED THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Vismodegib",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1587553565\">",
"      EGFR pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H175770610\">",
"      SYSTEMIC CHEMOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ALLOGENIC ORGAN TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/7619\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/7619|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/9/22679\" title=\"picture 1\">",
"      CR to cetuximab for intransit metastases of SCC of the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/7619|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/0/5134\" title=\"table 1\">",
"      TNM stage cutaneous SCC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=related_link\">",
"      Nevoid basal cell carcinoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/42/10922?source=related_link\">",
"      Systemic chemotherapy for cancer in elderly persons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=related_link\">",
"      Treatment and prognosis of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=related_link\">",
"      Treatment and prognosis of cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24712?source=related_link\">",
"      Treatment of basal cell carcinomas at high risk for recurrence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_61_14294="Interferon alfa-2b: Patient drug information";
var content_f13_61_14294=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Interferon alfa-2b: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29576?source=see_link\">",
"     see \"Interferon alfa-2b: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/47/40695?source=see_link\">",
"     see \"Interferon alfa-2b: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Intron&reg; A",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F183205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Intron&reg; A",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10031307\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Alpha interferons may cause or make diseases of the mind worse. Taking one's own life, ideas of killing yourself or murder, low mood (depression), forceful actions, hallucinations, psychoses, and relapse of drug addiction have happened with use. Alpha interferons may make infections worse, cause blood flow problems or some autoimmune diseases. If you think you have any of these health problems, call your doctor right away. Side effects such as low blood pressure, a fast heartbeat, and heart attacks have happened while taking alpha interferons. If you have very bad signs or if signs of these health problems get worse, talk with your doctor about stopping this drug. Problems are most often fixed after you stop the drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691858",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat genital warts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691880",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hepatitis B and C infections.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692078",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin wounds in patients with AIDS-related Kaposi's sarcoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to interferon alfa-2b or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703323",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Autoimmune disease, confusion caused by liver disease, fluid in your belly, liver disease, or very low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703752",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had a transplant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a drug or drinking problem, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any eye problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor. The flu-like side effects of interferon may be stressful to heart patients.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697268",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high cholesterol or triglyceride levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness or thoughts of taking your own life, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031316\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699006",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain or bloody loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696011",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime to help with flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696152",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Treating genital warts is done in a doctor's office.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose, brand, or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699572",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store unopened vials in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10764 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-4A54400AA2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14294=[""].join("\n");
var outline_f13_61_14294=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183204\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183205\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031307\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031309\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031308\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031313\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031314\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031316\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031311\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031312\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031317\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031318\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29576?source=related_link\">",
"      Interferon alfa-2b: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/47/40695?source=related_link\">",
"      Interferon alfa-2b: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_61_14295="Classification of complex acetabular fractures";
var content_f13_61_14295=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F55805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F55805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Letournel and Judet classification of complex acetabulum fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 505px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Posterior wall and posterior column. B) Transverse and posterior wall. C) T-shaped. D) Anterior column and posterior hemi-transverse. E) Anterior and posterior columns.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Matta, JM. Surgical Treatment of Acetabular Fractures. In: Skeletal Trauma: Basic Science, Management, and Reconstruction, Browner, BD, Jupiter, JB, Levine, AM, Trafton, PG (Eds), Saunders, Philadelphia 2003. p. 1110. Illustrations used with permission of Elsevier Inc. All rights reserved. Copyright &copy;2003 Elsevier Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14295=[""].join("\n");
var outline_f13_61_14295=null;
var title_f13_61_14296="Skin lesions pts uremic pruritis";
var content_f13_61_14296=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F62257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F62257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 615px\">",
"   <div class=\"ttl\">",
"    Skin lesions in patients with uremic pruritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 595px; height: 528px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Skin affected in patients with uraemic pruritus.",
"    <br/>",
"    (A) Scratches on the arm hosting the fistula.",
"    <br/>",
"    (B) Deep scars on the shoulders and the back of a female patient on haemodialysis.",
"    <br/>",
"    (C) Prurigo nodularis with excoreations and superinfection on the forearm of a patient on peritoneal dialysis.",
"    <br/>",
"    (D) Kyrles disease on the back of a patient on haemodialysis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus--new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17:1558, by permission of Oxford University Press. Copyright &copy; 2002.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14296=[""].join("\n");
var outline_f13_61_14296=null;
var title_f13_61_14297="Etiology of acute pancreatitis";
var content_f13_61_14297=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology of acute pancreatitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14297/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14297/contributors\">",
"     Santhi Swaroop Vege, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14297/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14297/contributors\">",
"     David C Whitcomb, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14297/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14297/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/61/14297/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pancreatitis is an inflammatory condition of the pancreas characterized clinically by abdominal pain and elevated levels of pancreatic enzymes in the blood [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The pathogenesis of acute pancreatitis is not fully understood. Nevertheless, a number of conditions are known to induce this disorder with varying degrees of certainty, with gallstones and chronic alcohol abuse accounting for 75 percent of cases in the United States (",
"    <a class=\"graphic graphic_table graphicRef78423 \" href=\"UTD.htm?13/16/13580\">",
"     table 1",
"    </a>",
"    ). This list will undoubtedly continue to grow, and the number of cases diagnosed as \"idiopathic\" will decrease as our understanding of the disease improves.",
"   </p>",
"   <p>",
"    This topic review will discuss the etiology of acute pancreatitis. The clinical manifestations, diagnosis, general principles of therapy, and pathogenesis of acute pancreatitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44504?source=see_link\">",
"     \"Predicting the severity of acute pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/35/7738?source=see_link\">",
"     \"Treatment of acute pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/57/38809?source=see_link\">",
"     \"Pancreatic debridement\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44774?source=see_link\">",
"     \"Pathogenesis of acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE AND MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate assessment of the incidence and mortality of acute pancreatitis is difficult as mild pancreatitis may be subclinical and deaths may occur before the diagnosis is made in severe and fulminant attacks.",
"   </p>",
"   <p>",
"    The reported annual incidence of acute pancreatitis has ranged from 4.9 to 35 per 100,000 population [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/3\">",
"     3",
"    </a>",
"    ]. Acute pancreatitis is a leading cause of hospitalization in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/4\">",
"     4",
"    </a>",
"    ]. The incidence of acute pancreatitis is increasing in many European and Scandinavian countries due to increased alcohol consumption and better diagnostic capability [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/5\">",
"     5",
"    </a>",
"    ]. In a retrospective study from the Netherlands, the observed incidence of acute pancreatitis increased by 28 percent between 1985 and 1995.",
"   </p>",
"   <p>",
"    Advances in diagnostic and therapeutic interventions have led to a decrease in mortality from acute pancreatitis, especially in those with severe, often necrotizing pancreatitis. Mortality in acute pancreatitis is usually due to systemic inflammatory response syndrome and organ failure in the first two-week period, while after two weeks it is usually due to sepsis and its complications [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A multicenter prospective study of 1005 patients with acute pancreatitis reported overall mortality of 5 percent (1.5 percent in mild acute pancreatitis and 17 percent in severe pancreatitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/8\">",
"     8",
"    </a>",
"    ]. While the overall mortality in all hospitalized patients with acute pancreatitis is approximately 10 percent (range 2 to 22 percent), the mortality in the subset with severe acute pancreatitis may be as high as 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a systematic review of studies of acute pancreatitis, overall mortality was approximately 5 percent, 3 percent, and 17 percent in all cases of acute pancreatitis, interstitial, and necrotizing pancreatitis, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/9\">",
"     9",
"    </a>",
"    ]. In patients with necrotizing pancreatitis, the mortality rate was 12 percent with sterile necrosis, 30 percent with infected necrosis, and 47 percent with multisystem organ failure. However, mortality rates in necrotizing pancreatitis may be lower in centers of expertise (range 6 to 9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/6,10\">",
"     6,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H822795\">",
"    <span class=\"h1\">",
"     MECHANICAL AMPULLARY OBSTRUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical ampullary obstruction can be induced by gallstone and a variety of disorders (",
"    <a class=\"graphic graphic_table graphicRef78423 \" href=\"UTD.htm?13/16/13580\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Gallstones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical ampullary obstruction can be induced by gallstones. The mechanism by which the passage of gallstones induces pancreatitis is unknown. Two factors have been suggested as the possible initiating event in gallstone pancreatitis: reflux of bile into the pancreatic duct due to transient obstruction of the ampulla during passage of gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/11\">",
"     11",
"    </a>",
"    ]; or obstruction at the ampulla secondary to stone(s) or edema resulting from the passage of a stone [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/12\">",
"     12",
"    </a>",
"    ]. Cholecystectomy and clearing the common bile duct of stones prevents recurrence, confirming the cause-and-effect relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallstones (including microlithiasis) are the most common cause of acute pancreatitis in most areas of the world accounting for 35 to 40 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/14\">",
"     14",
"    </a>",
"    ]. However, only 3 to 7 percent of patients with gallstones develop pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/13,15\">",
"     13,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H524685462\">",
"    <span class=\"h3\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gender and stone size may be risk factors for gallstone pancreatitis. The risk of developing acute pancreatitis in patients with gallstones is greater in men; however, the incidence of gallstone pancreatitis is higher in women due to a higher prevalence of gallstones [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/13\">",
"     13",
"    </a>",
"    ]. Small gallstones are associated with an increased risk of pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/16\">",
"     16",
"    </a>",
"    ]. One study found that stones with a diameter of less than 5 mm were significantly more likely than larger stones to pass through the cystic duct and cause obstruction at the ampulla (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Biliary sludge and microlithiasis'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of gallstone pancreatitis should be suspected if the patient has a prior history of biliary colic.",
"   </p>",
"   <p>",
"    Laboratory values obtained during the acute attack may assist in making the diagnosis. A meta-analysis found that an elevated serum alanine aminotransferase (ALT) concentration was the most clinically useful parameter in predicting a gallstone etiology in patients with acute pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/17\">",
"     17",
"    </a>",
"    ]. In this review, a serum ALT concentration of 150",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    or more (approximately a threefold elevation) had a positive predictive value of 95 percent for the diagnosis of gallstone pancreatitis. The aspartate aminotransferase (AST) concentration was nearly as useful as ALT, while the total bilirubin and alkaline phosphatase concentrations did not assist in making the diagnosis.",
"   </p>",
"   <p>",
"    In addition, all patients with a first attack of acute pancreatitis (irrespective of elevations in liver tests) should have an abdominal ultrasound to search for gallstones, common duct stones, or signs of extrahepatic biliary tract obstruction.",
"   </p>",
"   <p>",
"    If gallstone pancreatitis is suspected and there is no history of alcohol abuse, early endoscopic retrograde cholangiogram (ERCP) with papillotomy or surgical intervention to remove bile duct stones may decrease the complication rate [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/35/7738?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment of acute pancreatitis\", section on 'Gallstone pancreatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Biliary sludge and microlithiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with biliary sludge are asymptomatic. However, biliary sludge is commonly found in 20 to 40 percent of patients with acute pancreatitis with no obvious cause. In the absence of any other etiology, biliary sludge should be suspected in patients with acute pancreatitis with a transient elevation in liver tests.",
"   </p>",
"   <p>",
"    Biliary sludge is a viscous suspension in gallbladder bile that may contain small stones (&lt;5 mm in diameter) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/19\">",
"     19",
"    </a>",
"    ]. It is formed by modification of hepatic bile by gallbladder mucosa; thus, hepatic bile samples may be insufficient for its diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/20\">",
"     20",
"    </a>",
"    ]. Microscopic analysis of bile in patients with sludge often shows cholesterol monohydrate crystals or calcium bilirubinate granules [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sludge is typically found in patients with functional or mechanical bile stasis, such as those undergoing a prolonged fast, with distal bile duct obstruction, or on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    . In addition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    can complex with bile to form a sludge within the biliary system when its solubility in bile is exceeded; stone formation can rarely occur [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Biliary disease disappears after stopping the drug.",
"   </p>",
"   <p>",
"    On ultrasound, sludge appears as a mobile, low-amplitude echo that layers in the most dependent part of the gallbladder and is not associated with shadowing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other conditions causing obstruction of the ampulla that have been associated with pancreatitis include biliary ascariasis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/24\">",
"     24",
"    </a>",
"    ], periampullary diverticula [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/25\">",
"     25",
"    </a>",
"    ], and pancreatic and periampullary tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/26\">",
"     26",
"    </a>",
"    ]. Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are being recognized increasingly and may occasionally present as acute pancreatitis, especially in elderly nonalcoholic males. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33288?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of intraductal papillary mucinous neoplasm of the pancreas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ALCOHOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcohol is responsible for approximately 30 percent of cases of acute pancreatitis in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/27\">",
"     27",
"    </a>",
"    ]. Approximately 10 percent of chronic alcoholics develop attacks of clinically acute pancreatitis that are indistinguishable from other forms of acute pancreatitis.",
"   </p>",
"   <p>",
"    Alcohol may act by increasing the synthesis of enzymes by pancreatic acinar cells to synthesize the digestive and lysosomal enzymes that are thought to be responsible for acute pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/28\">",
"     28",
"    </a>",
"    ] or over-sensitization of acini to cholecystokinin [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44774?source=see_link\">",
"     \"Pathogenesis of acute pancreatitis\"",
"    </a>",
"    .) However, the exact mechanism of pancreatic injury, the genetic and environmental factors that influence the development of pancreatitis in alcoholics, and the reason why only a small proportion of alcoholics develop pancreatitis, are unclear.",
"   </p>",
"   <p>",
"    There is debate about the presence of underlying chronic pancreatitis in patients presenting with acute alcoholic pancreatitis. It was initially thought that alcohol causes chronic pancreatitis, and that alcoholics who present with clinically acute pancreatitis have underlying chronic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/30\">",
"     30",
"    </a>",
"    ]. However, some long-term follow-up studies of patients with acute alcoholic pancreatitis have shown that not all patients progress to chronic pancreatitis, even with continued alcohol abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/31\">",
"     31",
"    </a>",
"    ]. This suggests that some alcoholics may have nonprogressive acute alcohol-induced pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SMOKING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Until recently, smoking was thought to be a risk factor due to its association with alcohol. However, at least four large studies have suggested that cigarette smoking is an independent risk factor for acute and chronic pancreatitis by mechanisms that are unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/33-36\">",
"     33-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     HYPERTRIGLYCERIDEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum triglyceride concentrations above 1000",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    can precipitate attacks of acute pancreatitis, although the pathogenesis of inflammation in this setting is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/37\">",
"     37",
"    </a>",
"    ]. Hypertriglyceridemia may account for 1 to 3.8 percent of cases of acute pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pancreatitis in hypertriglyceridemic subjects has been reported in children with inherited disorders of lipoprotein metabolism that are associated with severe hypertriglyceridemia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Acquired causes of hypertriglyceridemia include obesity, diabetes mellitus, hypothyroidism, pregnancy, estrogen or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    therapy, glucocorticoid excess, nephrotic syndrome, and beta blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=see_link\">",
"     \"Approach to the patient with hypertriglyceridemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31064?source=see_link\">",
"     \"Hypertriglyceridemia-induced acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H266287567\">",
"    <span class=\"h1\">",
"     POST-ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymptomatic hyperamylasemia occurs in 35 to 70 percent of patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/44\">",
"     44",
"    </a>",
"    ]. A diagnosis of post-ERCP pancreatitis is generally made if the hyperamylasemia is accompanied by persistent severe upper abdominal pain, often with nausea and vomiting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=see_link&amp;anchor=H7#H7\">",
"     \"Post-ERCP pancreatitis\", section on 'Early diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute pancreatitis occurs in about 3 percent of patients undergoing diagnostic ERCP, 5 percent undergoing therapeutic ERCP, and up to 25 percent undergoing sphincter of Oddi manometric studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29126?source=see_link\">",
"     \"Treatment of sphincter of Oddi dysfunction\"",
"    </a>",
"    .) Several strategies can decrease the risk of post-ERCP pancreatitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=see_link&amp;anchor=H8#H8\">",
"     \"Post-ERCP pancreatitis\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HYPERCALCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although an uncommon complication, hypercalcemia of any cause can lead to acute pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28007?source=see_link\">",
"     \"Etiology of hypercalcemia\"",
"    </a>",
"    .) Proposed mechanisms include deposition of calcium in the pancreatic duct and calcium activation of trypsinogen within the pancreatic parenchyma [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are numerous reports associating hyperparathyroidism with pancreatitis. However, the actual incidence of acute pancreatitis in patients with hyperparathyroidism is low. In one large series, for example, acute pancreatitis occurred in only 17 of 1153 patients (1.5 percent) with hyperparathyroidism, a frequency similar to that in the general hospital population [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/49\">",
"     49",
"    </a>",
"    ]. In addition, other potential causes were evident in 11 of the 17 cases, and the symptoms of acute pancreatitis were not ameliorated by treatment of the hypercalcemia.",
"   </p>",
"   <p>",
"    The low incidence of pancreatitis in patients with chronic hypercalcemia suggests that other factors (eg, acute elevations of serum calcium) are responsible for pancreatitis in these patients. An experimental model, for example, found that acute calcium infusions in rats led to hyperamylasemia and dose-dependent morphological alterations characteristic of acute pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     GENETIC MUTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several genetic mutations have been associated with pancreatitis. Inherited forms of pancreatitis may present as recurrent acute pancreatitis but eventually progress to chronic pancreatitis.",
"   </p>",
"   <p>",
"    Gain-of-function mutations in the serine protease 1 gene (PRSS1) on chromosome 7q35, which encodes cationic trypsinogen, results in an autosomal dominantly inherited form of hereditary pancreatitis. Mutations in the cystic fibrosis gene (CFTR) have been associated with an autosomal recessively inherited pancreatitis. Pancreatitis has also been associated with low penetrance mutations in the serine protease inhibitor Kazal type 1 (SPINK1), which may act as a disease modifier and lower the threshold for developing pancreatitis from other genetic or environmental factors. Mutations in chymotrypsin C (CTRC) have also been identified in pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37288?source=see_link&amp;anchor=H2#H2\">",
"     \"Hereditary pancreatitis\", section on 'Genetics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatitis due to medications is rare (0.3 to 1.4 percent), although limited data suggest that the incidence may be increasing [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/51-54\">",
"     51-54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Drug-induced pancreatitis is classified (class I-IV) based on the number of cases reported, demonstration of a consistent latency period (time from initiation of drug to development of pancreatitis), and reaction with rechallenge (",
"    <a class=\"graphic graphic_table graphicRef60555 \" href=\"UTD.htm?27/44/28363\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/55\">",
"     55",
"    </a>",
"    ]. Class I and II drugs have the greatest potential for causing acute pancreatitis (",
"    <a class=\"graphic graphic_table graphicRef70788 \" href=\"UTD.htm?33/50/34605\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Several different mechanisms of drug-induced pancreatitis have been proposed. These mechanisms include immunologic reactions (eg, 6-mercaptopurine, aminosalicylates, sulfonamides), direct toxic effect (eg, diuretics, sulfonamides), accumulation of a toxic metabolite (valproic acid,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/43/22199?source=see_link\">",
"     pentamidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    ), ischemia (diuretics,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ), intravascular thrombosis (estrogen), and an increased viscosity of pancreatic juice (diuretics and steroids).",
"   </p>",
"   <p>",
"    Drug-induced pancreatitis has no distinguishing clinical features. A high index of suspicion and careful drug history are therefore essential for making the diagnosis. The time course of developing the disorder depends upon the drug involved. As an example, pancreatitis may develop within a few weeks after beginning a drug associated with an immunologically mediated adverse reaction; in this setting, the patient may also have a rash and eosinophilia. In contrast, patients taking valproic acid,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/43/22199?source=see_link\">",
"     pentamidine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    may not develop pancreatitis until after many months of use, presumably due to the chronic accumulation of toxic metabolic products. Proving the association with a particular drug may not always be straightforward, even in suspected cases. Thus, patients restarted on their medications should be closely monitored and the drug promptly discontinued if symptoms recur.",
"   </p>",
"   <p>",
"    The prognosis of drug-induced pancreatitis is generally excellent and mortality is low [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     INFECTIONS AND TOXINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatitis has been associated with the following infections, although the frequency with which these infections lead to pancreatitis is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Viruses &ndash; Mumps, coxsackievirus, hepatitis B, cytomegalovirus, varicella-zoster, herpes simplex, HIV",
"     </li>",
"     <li>",
"      Bacteria &ndash; Mycoplasma, Legionella, Leptospira, Salmonella",
"     </li>",
"     <li>",
"      Fungi &ndash; Aspergillus",
"     </li>",
"     <li>",
"      Parasites &ndash; Toxoplasma, Cryptosporidium, Ascaris",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Only 70 percent of individuals have a characteristic syndrome caused by the infectious agent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/57\">",
"     57",
"    </a>",
"    ]. Thus, the routine search for an infectious etiology in idiopathic pancreatitis is",
"    <strong>",
"     not",
"    </strong>",
"    recommended. In addition, the value of treating the infectious agent to reverse pancreatitis remains unknown.",
"   </p>",
"   <p>",
"    Acute pancreatitis has been associated with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/58\">",
"     58",
"    </a>",
"    ]. In one series, acute pancreatitis occurred in 4.7 percent of 939 hospitalized patients who were seropositive for HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/59\">",
"     59",
"    </a>",
"    ]. Acute pancreatitis may be part of primary HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/60\">",
"     60",
"    </a>",
"    ] but more frequently occurs as a complication of medications taken to treat the virus (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    ) or opportunistic infections (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/43/22199?source=see_link\">",
"     pentamidine",
"    </a>",
"    ), or due to the opportunistic infection itself (eg, Pneumocystis carinii, Mycobacterium avium-intracellulare) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The venom of arachnids and reptiles (brown recluse spider, some scorpions, and the Gila monster lizard) has been associated with pancreatitis due to cholinergic stimulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TRAUMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt or penetrating trauma can damage the pancreas, although these injuries are uncommon due to the retroperitoneal location of the gland [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. The diagnosis of traumatic pancreatitis is difficult and requires a high degree of suspicion. Trauma can range from a mild contusion to a severe crush injury or transection of the gland; the latter usually occurs at the point where the gland crosses over the spine. This injury can cause acute duct rupture and pancreatic ascites. Healing of pancreatic ductal injuries can lead to scarring and stricture of the main pancreatic duct, with resultant obstructive pancreatitis in the gland downstream from the stricture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PANCREAS DIVISUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreas divisum is a common anatomic variant, occurring in approximately 7 percent of autopsy series. It results from failure of the embryologically derived dorsal and ventral pancreas to fuse, resulting in separate pancreatic ductal systems. Whether pancreas divisum causes pancreatitis or is an incidental finding is controversial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3431?source=see_link\">",
"     \"Anatomy and clinical significance of pancreas divisum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     VASCULAR DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic ischemia is an uncommon cause of clinically significant pancreatitis. Ischemia with resultant pancreatitis has been reported in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vasculitis (systemic lupus erythematosus and polyarteritis nodosa) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/63\">",
"       63",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Atheroembolism [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/64,65\">",
"       64,65",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Intraoperative hypotension [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/66\">",
"       66",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hemorrhagic shock [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/67\">",
"       67",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A porcine model of cardiogenic shock induced by pericardial tamponade found that pancreatic vasospasm was responsible for significant selective pancreatic ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients have mild attacks of pancreatitis secondary to ischemia, although fatal necrotizing pancreatitis can occur. In one report, for example, 81 of 300 patients (27 percent) undergoing cardiac surgery developed hyperamylasemia and three patients subsequently developed necrotizing pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/66\">",
"     66",
"    </a>",
"    ]. Preoperative renal insufficiency, postoperative hypotension, and perioperative administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15799?source=see_link\">",
"     calcium chloride",
"    </a>",
"    were significant risk factors for the development of pancreatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pancreatitis is rare during pregnancy. In a retrospective cohort study of 16,000 deliveries, only eight cases of acute pancreatitis were noted; five were due to gallstones and the others were idiopathic [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/69\">",
"     69",
"    </a>",
"    ]. A number of cases of hyperlipidemia associated with pancreatitis in pregnancy have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/70\">",
"     70",
"    </a>",
"    ]. Hyperlipidemic gestational pancreatitis usually occurs only in women with preexisting abnormalities in lipid metabolism, although it is not clear if pregnancy increases the risk of pancreatitis in women who have underlying hypertriglyceridemia.",
"   </p>",
"   <p>",
"    In a retrospective cohort study of 96 pregnant patients with acute pancreatitis, the majority (96 percent) did not have complications [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/71\">",
"     71",
"    </a>",
"    ]. Fetal outcomes were good, although there was a higher risk of prematurity as with other severe, inflammatory diseases. Acute pancreatitis was complicated by disseminated vascular coagulation in the third trimester in 3 percent. Patients who developed pancreatitis in the first trimester had the highest risk of fetal loss (20 percent) and preterm delivery (16 percent).",
"   </p>",
"   <p>",
"    The management of acute and chronic pancreatitis in pregnancy is similar to that in nonpregnant individuals. If",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    is required, adjustments should be made to meet the needs of the gravida [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/72\">",
"     72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31064?source=see_link\">",
"     \"Hypertriglyceridemia-induced acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     IDIOPATHIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;No obvious etiology is identifiable by history, laboratory tests, and gallbladder ultrasound in up to 30 percent of patients with acute pancreatitis. After an extensive work-up for recurrent pancreatitis (including magnetic resonance imaging",
"    <span class=\"nowrap\">",
"     [MRI]/magnetic",
"    </span>",
"    resonance cholangiopancreatography [MRCP], endoscopic ultrasound [EUS], endoscopic retrograde cholangiopancreatography [ERCP], analysis of bile for microlithiasis, and sphincter of Oddi manometry), approximately 15 to 25 percent of patients with acute pancreatitis are idiopathic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H98114689\">",
"    <span class=\"h1\">",
"     OTHER CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another rare cause of recurrent pancreatitis is celiac disease, where duodenal inflammation and papillary stenosis may be the mechanisms for pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/73\">",
"     73",
"    </a>",
"    ]. Autoimmune pancreatitis can sometimes present as acute pancreatitis, although the usual presentation is by weight loss, jaundice, and pancreatic enlargement on imaging, mimicking a neoplasm. Finally, there are reports of pancreatitis occurring in patients with anorexia nervosa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40168?source=see_link\">",
"     \"Autoimmune pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=see_link&amp;anchor=H440186#H440186\">",
"     \"Anorexia nervosa in adults and adolescents: Medical complications and their management\", section on 'Other'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DETERMINING THE ETIOLOGY OF ACUTE PANCREATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of acute pancreatitis can be established in at least 75 percent of patients. An approach to establishing the cause of acute pancreatitis is outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef76483 \" href=\"UTD.htm?36/1/36892\">",
"     table 4",
"    </a>",
"    ). Our approach to determining the etiology of acute pancreatitis, which is largely consistent with guidelines issued by the American Gastroenterological Association (AGA), is outlined below [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14297/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The history should focus on previous symptoms or documentation of gallstones, alcohol use, history of hypertriglyceridemia or hypercalcemia, family history of pancreatic disease, prescription and nonprescription drug history, history of trauma, and the presence of concomitant autoimmune diseases.",
"     </li>",
"     <li>",
"      On admission, all patients should have a serum amylase or lipase, triglyceride level, calcium level, and liver biochemistries. Hypertriglyceridemia may be missed if obtained after prolonged fasting. Fasting triglyceride levels should be obtained after recovery once the patient has resumed a normal diet. In patients with suspicion of autoimmune pancreatitis, antinuclear antibody levels and serum IgG4 levels should be obtained.",
"     </li>",
"     <li>",
"      An abdominal ultrasound should be obtained on admission in all patients with acute pancreatitis to evaluate for cholelithiasis or choledocholithiasis. The examination should be repeated after recovery if the initial examination is inadequate or if clinical suspicion for gallstones remains.",
"     </li>",
"     <li>",
"      Extensive or invasive evaluation is usually not recommended in those with a single episode of pancreatitis who are younger than 40 but some reports recommend endoscopic ultrasound (EUS) even after one attack if the cause is not clear to look for pancreatic ductal abnormalities, small tumors at or near the ampulla, microlithiasis in the gallbladder or bile duct, and early chronic pancreatitis. Undiagnosed early chronic pancreatitis may, in fact, be a very common cause of \"idiopathic recurrent acute pancreatitis\". Endoscopic retrograde cholangiopancreatography (ERCP) should not be performed after a single episode of acute pancreatitis in the absence of laboratory or imaging evidence of choledocholithiasis.",
"     </li>",
"     <li>",
"      In patients with unexplained pancreatitis who are at risk for underlying malignancy (age older than 40) and or worrisome clinical features including weight loss and new onset of diabetes, CT with pancreas protocol or magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) should be obtained. Alternatively, EUS can be used to screen for malignancy, ampullary masses, pancreatic ductal dilatation, features of chronic pancreatitis and microlithiasis. If the above imaging tests are abnormal, ERCP should be performed.",
"     </li>",
"     <li>",
"      In patients with recurrent episodes of pancreatitis (irrespective of age), EUS",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ERCP should be considered. EUS is the preferred initial test. If ERCP is performed, it should be performed by an endoscopist with experience in pancreatic endotherapy. It should be noted that there is significant controversy about sphincter of Oddi dysfunction and pancreas divisum as causes of idiopathic recurrent acute pancreatitis. If the etiology is not identified on ERCP, sphincter of Oddi manometry may be considered and performed in the same setting to measure biliary and pancreatic pressures. Alternatively, one could proceed to biliary and or pancreatic sphincterotomies without measuring biliary and pancreatic pressures with a presumed diagnosis of type 2 sphincter of Oddi dysfunction.",
"     </li>",
"     <li>",
"      We look for an inherited cause of pancreatitis in patients with a strong family history compatible with pancreatitis or with onset of symptoms at a young age (&lt;35 years). All patients in whom genetic testing is done should have genetic counseling prior to and after testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is also important to note the limitations in diagnostic evaluation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Invasive testing (such as sphincter of Oddi manometry) is associated with procedure-related complications. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12874?source=see_link\">",
"       \"Clinical manifestations and diagnosis of sphincter of Oddi dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The relationship between some of the findings, such as pancreas divisum, sphincter of Oddi dysfunction, and microlithiasis, and pancreatitis is not always clear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3431?source=see_link\">",
"       \"Anatomy and clinical significance of pancreas divisum\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Methods for detection of microlithiasis have not been standardized.",
"     </li>",
"     <li>",
"      The accuracy of testing and the results of endoscopic intervention depend upon the operator; thus, results may not be generalizable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/26/42401?source=see_link\">",
"       \"Patient information: Pancreatitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/36/41537?source=see_link\">",
"       \"Patient information: Acute pancreatitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute pancreatitis is an inflammatory condition of the pancreas characterized clinically by abdominal pain and elevated levels of pancreatic enzymes in the blood. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of conditions are known to cause acute pancreatitis (",
"      <a class=\"graphic graphic_table graphicRef78423 \" href=\"UTD.htm?13/16/13580\">",
"       table 1",
"      </a>",
"      ). Of these, gallstones and chronic alcohol abuse account for 75 percent of cases in the United States. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Gallstones'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Alcohol'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To determine the etiology of acute pancreatitis, all patients should have a history, physical examination, laboratory evaluation (serum amylase or lipase, triglyceride level, calcium level, and liver biochemistries), and abdominal ultrasound (repeated, if initially negative for gallstones). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Determining the etiology of acute pancreatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the initial evaluation does not yield an etiology, we pursue endoscopic ultrasound (EUS), even after one attack in patients younger than 40 years, to detect small pancreatic cancers, ampullary masses, pancreatic ductal dilatation, features of chronic pancreatitis and microlithiasis. Magnetic resonance cholangiopancreatography (MRCP) may be performed before EUS.",
"     </li>",
"     <li>",
"      In patients with unexplained pancreatitis who are at risk for underlying malignancy (age older than 40)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      worrisome clinical features including weight loss and new onset of diabetes, CT with pancreas protocol or magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) should be obtained. Alternatively, endoscopic ultrasound (EUS) can be used to screen for malignancy, ampullary masses, pancreatic ductal dilatation, features of chronic pancreatitis and microlithiasis. If the above imaging tests are abnormal, endoscopic retrograde cholangiopancreatography (ERCP) should be performed. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Determining the etiology of acute pancreatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with recurrent episodes of pancreatitis (irrespective of age), EUS",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endoscopic retrograde cholangiopancreatography (ERCP) should be considered. EUS is the preferred initial test. ERCP is needed if main duct intraductal papillary mucinous neoplasm (IPMN) or a pancreatic ductal stricture is diagnosed on EUS. Its role in sphincter of Oddi dysfunction is controversial, especially in type 3. If ERCP is performed, it should be performed by an endoscopist with experience in pancreatic endotherapy. If the etiology is not identified on ERCP, sphincter of Oddi manometry should be considered and performed in the same setting to measure biliary and pancreatic pressures. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Determining the etiology of acute pancreatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We look for an inherited cause of pancreatitis in patients with a strong family history compatible with pancreatitis or with onset of symptoms at a young age (&lt;35 years). All patients in whom genetic testing is done should have genetic counseling prior to and after testing. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Genetic mutations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do",
"      <strong>",
"       not",
"      </strong>",
"      advise biliary microscopy as very few centers have access to this procedure at the time of EUS or ERCP. We do not routinely perform sphincter of Oddi manometry, but consider it only when the etiology is not identified on EUS and ERCP.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Sarles H. Pancreatitis symposium. Basel SK, Marseille 1963.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/2\">",
"      Sarles H. Revised classification of pancreatitis--Marseille 1984. Dig Dis Sci 1985; 30:573.",
"     </a>",
"    </li>",
"    <li>",
"     Vege SS, Yadav D, Chari ST. Pancreatitis. In: GI Epidemiology, 1st ed, Talley NJ, Locke GR, Saito YA (Eds), Blackwell Publishing, Malden, MA 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/4\">",
"      Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012; 143:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/5\">",
"      Toouli J, Brooke-Smith M, Bassi C, et al. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 2002; 17 Suppl:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/6\">",
"      Gloor B, M&uuml;ller CA, Worni M, et al. Late mortality in patients with severe acute pancreatitis. Br J Surg 2001; 88:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/7\">",
"      Mutinga M, Rosenbluth A, Tenner SM, et al. Does mortality occur early or late in acute pancreatitis? Int J Pancreatol 2000; 28:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/8\">",
"      Cavallini G, Frulloni L, Bassi C, et al. Prospective multicentre survey on acute pancreatitis in Italy (ProInf-AISP): results on 1005 patients. Dig Liver Dis 2004; 36:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/9\">",
"      Banks PA, Freeman ML, Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101:2379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/10\">",
"      Warshaw AL. Pancreatic necrosis: to debride or not to debride-that is the question. Ann Surg 2000; 232:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/11\">",
"      Opie EL. The etiology of acute hemorrhagic pancreatitis. Bull Johns Hopkins Hosp 1901; 12:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/12\">",
"      Lerch MM, Saluja AK, R&uuml;nzi M, et al. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology 1993; 104:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/13\">",
"      Riela A, Zinsmeister AR, Melton LJ, DiMagno EP. Etiology, incidence, and survival of acute pancreatitis in Olmsted County, Minnesota. Gastroenterology 1991; 100:A296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/14\">",
"      Forsmark CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007; 132:2022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/15\">",
"      Moreau JA, Zinsmeister AR, Melton LJ 3rd, DiMagno EP. Gallstone pancreatitis and the effect of cholecystectomy: a population-based cohort study. Mayo Clin Proc 1988; 63:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/16\">",
"      Venneman NG, Renooij W, Rehfeld JF, et al. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis. Hepatology 2005; 41:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/17\">",
"      Tenner S, Dubner H, Steinberg W. Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis. Am J Gastroenterol 1994; 89:1863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/18\">",
"      Sharma VK, Howden CW. Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis. Am J Gastroenterol 1999; 94:3211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/19\">",
"      Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med 1999; 130:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/20\">",
"      Ko CW, Schulte SJ, Lee SP. Biliary sludge is formed by modification of hepatic bile by the gallbladder mucosa. Clin Gastroenterol Hepatol 2005; 3:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/21\">",
"      Ros E, Navarro S, Bru C, et al. Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991; 101:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/22\">",
"      Lopez AJ, O'Keefe P, Morrissey M, Pickleman J. Ceftriaxone-induced cholelithiasis. Ann Intern Med 1991; 115:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/23\">",
"      Ettestad PJ, Campbell GL, Welbel SF, et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis 1995; 171:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/24\">",
"      Khuroo MS, Zargar SA, Mahajan R. Hepatobiliary and pancreatic ascariasis in India. Lancet 1990; 335:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/25\">",
"      Uomo G, Manes G, Ragozzino A, et al. Periampullary extraluminal duodenal diverticula and acute pancreatitis: an underestimated etiological association. Am J Gastroenterol 1996; 91:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/26\">",
"      K&ouml;hler H, Lankisch PG. Acute pancreatitis and hyperamylasaemia in pancreatic carcinoma. Pancreas 1987; 2:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/27\">",
"      Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med 2008; 168:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/28\">",
"      Apte MV, Wilson JS, McCaughan GW, et al. Ethanol-induced alterations in messenger RNA levels correlate with glandular content of pancreatic enzymes. J Lab Clin Med 1995; 125:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/29\">",
"      Tiscornia OM, Celener D, Perec CJ, et al. Physiopathogenic basis of alcoholic pancreatitis: the effects of elevated cholinergic tone and increased \"pancreon\" ecbolic response to CCK-PZ. Mt Sinai J Med 1983; 50:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/30\">",
"      Migliori M, Manca M, Santini D, et al. Does acute alcoholic pancreatitis precede the chronic form or is the opposite true? A histological study. J Clin Gastroenterol 2004; 38:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/31\">",
"      Ammann RW, Heitz PU, Kl&ouml;ppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996; 111:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/32\">",
"      Hanck C, Singer MV. Does acute alcoholic pancreatitis exist without preexisting chronic pancreatitis? Scand J Gastroenterol 1997; 32:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/33\">",
"      Lindkvist B, Appelros S, Manjer J, et al. A prospective cohort study of smoking in acute pancreatitis. Pancreatology 2008; 8:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/34\">",
"      Tolstrup JS, Kristiansen L, Becker U, Gr&oslash;nbaek M. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med 2009; 169:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/35\">",
"      Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med 2009; 169:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/36\">",
"      Sadr-Azodi O, Andr&eacute;n-Sandberg &Aring;, Orsini N, Wolk A. Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population-based study. Gut 2012; 61:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/37\">",
"      Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990; 19:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/38\">",
"      Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90:2134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/39\">",
"      Krauss RM, Levy AG. Subclinical chronic pancreatitis in type I hyperlipoproteinemia. Am J Med 1977; 62:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/40\">",
"      Salen S, Kessler JI, Janowitz HD. The development of pancreatic secretory insufficiency in a patient with recurrent pancreatitis and type V hyperlipoproteinemia. Mt Sinai J Med 1970; 37:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/41\">",
"      Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol 2000; 95:2795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/42\">",
"      Glueck CJ, Lang J, Hamer T, Tracy T. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994; 123:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/43\">",
"      Hozumi Y, Kawano M, Saito T, Miyata M. Effect of tamoxifen on serum lipid metabolism. J Clin Endocrinol Metab 1998; 83:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/44\">",
"      Aliperti G. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am 1996; 6:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/45\">",
"      Brandwein SL, Sigman KM. Case report: milk-alkali syndrome and pancreatitis. Am J Med Sci 1994; 308:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/46\">",
"      Khoo TK, Vege SS, Abu-Lebdeh HS, et al. Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab 2009; 94:2115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/47\">",
"      Mith&ouml;fer K, Fern&aacute;ndez-del Castillo C, Frick TW, et al. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology 1995; 109:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/48\">",
"      Ward JB, Petersen OH, Jenkins SA, Sutton R. Is an elevated concentration of acinar cytosolic free ionised calcium the trigger for acute pancreatitis? Lancet 1995; 346:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/49\">",
"      Bess MA, Edis AJ, van Heerden JA. Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 1980; 243:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/50\">",
"      Rosendahl J, Witt H, Szmola R, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008; 40:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/51\">",
"      R&uuml;nzi M, Layer P. Drug-associated pancreatitis: facts and fiction. Pancreas 1996; 13:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/52\">",
"      Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf 1996; 14:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/53\">",
"      McArthur KE. Review article: drug-induced pancreatitis. Aliment Pharmacol Ther 1996; 10:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/54\">",
"      Spanier BW, Tuynman HA, van der Hulst RW, et al. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol 2011; 106:2183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/55\">",
"      Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/56\">",
"      Lankisch PG, Dr&ouml;ge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut 1995; 37:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/57\">",
"      Parenti DM, Steinberg W, Kang P. Infectious causes of acute pancreatitis. Pancreas 1996; 13:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/58\">",
"      Dassopoulos T, Ehrenpreis ED. Acute pancreatitis in human immunodeficiency virus-infected patients: a review. Am J Med 1999; 107:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/59\">",
"      Cappell MS, Marks M. Acute pancreatitis in HIV-seropositive patients: a case control study of 44 patients. Am J Med 1995; 98:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/60\">",
"      Rizzardi GP, Tambussi G, Lazzarin A. Acute pancreatitis during primary HIV-1 infection. N Engl J Med 1997; 336:1836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/61\">",
"      Wilson RH, Moorehead RJ. Current management of trauma to the pancreas. Br J Surg 1991; 78:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/62\">",
"      Gerson LB, Tokar J, Chiorean M, et al. Complications associated with double balloon enteroscopy at nine US centers. Clin Gastroenterol Hepatol 2009; 7:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/63\">",
"      Watts RA, Isenberg DA. Pancreatic disease in the autoimmune rheumatic disorders. Semin Arthritis Rheum 1989; 19:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/64\">",
"      Moolenaar W, Lamers CB. Cholesterol crystal embolization to liver, gallbladder, and pancreas. Dig Dis Sci 1996; 41:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/65\">",
"      Orvar K, Johlin FC. Atheromatous embolization resulting in acute pancreatitis after cardiac catheterization and angiographic studies. Arch Intern Med 1994; 154:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/66\">",
"      Fern&aacute;ndez-del Castillo C, Harringer W, Warshaw AL, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/67\">",
"      Warshaw AL, O'Hara PJ. Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1978; 188:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/68\">",
"      Reilly PM, Toung TJ, Miyachi M, et al. Hemodynamics of pancreatic ischemia in cardiogenic shock in pigs. Gastroenterology 1997; 113:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/69\">",
"      Jouppila P, Mokka R, Larmi TK. Acute pancreatitis in pregnancy. Surg Gynecol Obstet 1974; 139:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/70\">",
"      Roberts IM. Hyperlipidemic gestational pancreatitis. Gastroenterology 1993; 104:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/71\">",
"      Tang SJ, Rodriguez-Frias E, Singh S, et al. Acute pancreatitis during pregnancy. Clin Gastroenterol Hepatol 2010; 8:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/72\">",
"      Badgett T, Feingold M. Total parenteral nutrition in pregnancy: case review and guidelines for calculating requirements. J Matern Fetal Med 1997; 6:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14297/abstract/73\">",
"      Patel RS, Johlin FC Jr, Murray JA. Celiac disease and recurrent pancreatitis. Gastrointest Endosc 1999; 50:823.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5640 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-6EBEB1F6CE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14297=[""].join("\n");
var outline_f13_61_14297=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE AND MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H822795\">",
"      MECHANICAL AMPULLARY OBSTRUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Gallstones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Incidence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H524685462\">",
"      - Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Biliary sludge and microlithiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ALCOHOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SMOKING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HYPERTRIGLYCERIDEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H266287567\">",
"      POST-ERCP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HYPERCALCEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      GENETIC MUTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DRUGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      INFECTIONS AND TOXINS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TRAUMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PANCREAS DIVISUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      VASCULAR DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      IDIOPATHIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H98114689\">",
"      OTHER CAUSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DETERMINING THE ETIOLOGY OF ACUTE PANCREATITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/5640\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/5640|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/16/13580\" title=\"table 1\">",
"      Etiology of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/44/28363\" title=\"table 2\">",
"      Classification system of drug-induced acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/50/34605\" title=\"table 3\">",
"      Summary of drug-induced acute pancreatitis based on drug class",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/1/36892\" title=\"table 4\">",
"      Approach to establishing the cause of acute pancreatitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3431?source=related_link\">",
"      Anatomy and clinical significance of pancreas divisum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=related_link\">",
"      Anorexia nervosa in adults and adolescents: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=related_link\">",
"      Approach to the patient with hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40168?source=related_link\">",
"      Autoimmune pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12874?source=related_link\">",
"      Clinical manifestations and diagnosis of sphincter of Oddi dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28007?source=related_link\">",
"      Etiology of hypercalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37288?source=related_link\">",
"      Hereditary pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31064?source=related_link\">",
"      Hypertriglyceridemia-induced acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/57/38809?source=related_link\">",
"      Pancreatic debridement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/46/44774?source=related_link\">",
"      Pathogenesis of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33288?source=related_link\">",
"      Pathophysiology and clinical manifestations of intraductal papillary mucinous neoplasm of the pancreas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/36/41537?source=related_link\">",
"      Patient information: Acute pancreatitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/26/42401?source=related_link\">",
"      Patient information: Pancreatitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=related_link\">",
"      Post-ERCP pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/29/44504?source=related_link\">",
"      Predicting the severity of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/35/7738?source=related_link\">",
"      Treatment of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29126?source=related_link\">",
"      Treatment of sphincter of Oddi dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_61_14298="Overview of physical activity and strength training in children and adolescents";
var content_f13_61_14298=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of physical activity and strength training in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14298/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14298/contributors\">",
"     Pat R Vehrs, PhD, FACSM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14298/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14298/contributors\">",
"     Joseph Chorley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/61/14298/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/61/14298/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/61/14298/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports and recommendations from professional organizations and federal agencies have increased public awareness of the health benefits associated with regular physical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. A panel convened by the United States Centers for Disease Control and Prevention (CDC) recommends that school-age children participate in at least 60 minutes per day of moderate to vigorous physical activity that is developmentally appropriate and enjoyable [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. The 60 minutes of daily physical activity should include activities that strengthen muscles and bones on at least three days per week [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The activity may occur in the context of play, games, sports, work, transportation, recreation, physical education, or planned exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]. Various methods of applying resistance to movement can be used to strengthen muscles, including lifting weights or using resistance bands [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Increased levels of physical activity and fitness are associated with reduced risk of disease in adulthood (eg, cardiovascular disease, diabetes, selected cancers, and musculoskeletal conditions). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of the benefits and risks of exercise\", section on 'Benefits of exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, these benefits usually are not the motivating factors for physical activity among children and adolescents. Children and adolescents participate in exercise or strength-training programs to improve physical fitness, performance, body composition, and body image, or to alleviate boredom and to socialize [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The benefits of physical activity and the potential benefits and risks of strength training in children and adolescents will be reviewed here. This information can be used by clinicians to counsel children and families regarding the development of an overall physical fitness program that includes strength training.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the discussion below, the terms child and children refer to boys and girls who have not yet developed secondary sex characteristics (Tanner stages 1 and 2, preadolescence). Adolescence refers to the period of time between childhood and adulthood (Tanner stages 3 and 4). The term youth broadly refers to both children and adolescents.",
"   </p>",
"   <p>",
"    Definitions related to physical fitness, activity, exercise, and competitive sports related to strength training are provided below [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/6,8-10\">",
"     6,8-10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical fitness &ndash; A set of physical attributes that enable one to perform daily physical activities. Health-related physical fitness encompasses cardiorespiratory endurance, muscular strength and endurance, flexibility, and body composition. Sports-related physical fitness includes the additional components of balance, agility, power, reaction time, speed, and coordination.",
"     </li>",
"     <li>",
"      Physical activity &ndash; Any bodily movement that results in an increase in energy expenditure.",
"     </li>",
"     <li>",
"      Exercise &ndash; A subset of physical activity that is carried out for the specific purpose of improving or maintaining one or more of the components of physical fitness. Exercise is planned, structured, and repetitive.",
"     </li>",
"     <li>",
"      Strength training (also called resistance training) &ndash; The systematic use of various methods of applying resistance to movement to increase one's ability to exert or resist force. Methods of applying resistance may include free weights, machines, body weight, elastic cords, tubing, or other devices.",
"     </li>",
"     <li>",
"      Weight training &ndash; The use of free weights (dumbbells and barbells), or machines as resistance.",
"     </li>",
"     <li>",
"      Weight lifting &ndash; A form of strength training or a competitive sport that contests maximal lifts using the snatch and clean-and-jerk (Olympic-style lifts).",
"     </li>",
"     <li>",
"      Power lifting &ndash; A competitive sport that contests maximal lifts using the squat, bench press, and dead lift.",
"     </li>",
"     <li>",
"      Body building &ndash; A competitive sport in which strength-training methods are used to increase muscle mass, symmetry, and definition. It does not involve competitive lifts [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHYSICAL ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1997, the United States Centers for Disease Control and Prevention (CDC) suggested multifaceted approaches to promote physical activity among young people [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/6\">",
"     6",
"    </a>",
"    ]. The guidelines recommend that health care providers, schools, the community, and the fitness industry cooperate to provide safe environments and facilities for developmentally appropriate physical activity, as well as appropriate instruction, supervision, and role models for youth. Although physical activity guidelines for adults have been updated several times since 1997 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/12-14\">",
"     12-14",
"    </a>",
"    ], recommendations specific to children and adolescents have remained consistent.",
"   </p>",
"   <p>",
"    The CDC has developed a Youth Physical Activity Guidelines Toolkit that can be used to promote youth physical activity. It is available at",
"    <a class=\"external\" href=\"file://www.cdc.gov/healthyYouth/physicalactivity/guidelines.htm\">",
"     www.cdc.gov/healthyYouth/physicalactivity/guidelines.htm",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Amount",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children should be encouraged to participate in regular physical activity to establish healthy lifestyle habits at an early age. Portions of a child's free time should be devoted to participation in play, recreation, sports, and other physical activities that improve each of the components of physical fitness.",
"   </p>",
"   <p>",
"    A panel convened by the CDC recommends that school-age children participate in at least 60 minutes per day of moderate to vigorous physical activity (MVPA) that is developmentally appropriate and enjoyable [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/3\">",
"     3",
"    </a>",
"    ]. The activity may occur in the context of play, games, sports, work, transportation, recreation, physical education, or planned exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]. Examples of moderate physical activity include hiking, skateboarding, and brisk walking; examples of vigorous physical activity include jumping rope, running, and sports such as soccer, basketball, and ice or field hockey [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/15\">",
"     15",
"    </a>",
"    ]. As part of the 60 minutes per day of MVPA, muscle-strengthening (eg, sit-ups, rope climbing, weight lifting, using resistance bands) and bone-strengthening activities (eg, jumping rope, running, skipping) are recommended three days per week [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Longitudinal data from the Study of Early Child Care and Youth Development (2000 to 2006) indicate that virtually all nine-year-old children met the CDC guideline for MVPA, engaging in an average of approximately three hours of MVPA per day (as measured by an accelerometer) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. However, by 15 years of age, MVPA declined to an average of 50",
"    <span class=\"nowrap\">",
"     minutes/day",
"    </span>",
"    on weekdays and 37",
"    <span class=\"nowrap\">",
"     minutes/day",
"    </span>",
"    on weekends, with only 32 and 18 percent of 15-year-olds meeting the CDC guidelines for MVPA on weekdays and weekends, respectively. According to the 2010 National Youth Physical Activity and Nutrition Survey, only 15 percent of high-school students participate in &ge;60 minutes of aerobic physical activity per day [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/18\">",
"     18",
"    </a>",
"    ]. Reduced physical activity levels in adolescence predict reduced physical activity levels in adulthood, which has potential long-term health implications [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Benefits of activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The health benefits of regular physical activity for adults are well established [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/6\">",
"     6",
"    </a>",
"    ]. They are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of the benefits and risks of exercise\", section on 'Benefits of exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An expert panel convened by the CDC in 2004 reviewed the literature regarding the effects of physical activity on health and behavior in school-age children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/3\">",
"     3",
"    </a>",
"    ]. They found strong evidence for beneficial effects on musculoskeletal health, several components of cardiovascular health, adiposity in overweight youth, and blood pressure in mildly hypertensive children. Among healthy youth, regular physical activity improves aerobic endurance, muscular strength, and bone density, and may decrease the risk of cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/20-28\">",
"     20-28",
"    </a>",
"    ]. In addition, physical activity in adolescents is associated with improvements in psychosocial well-being [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In a systematic review, participation in physical activity was positively related to academic performance in children; however only 2 of the 14 included studies reviewed were of high quality [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Development and maintenance of muscle strength and endurance is important in the performance of the activities of daily living, but also may improve performance in recreational or competitive activities. Strength training is a safe and effective method of developing muscular strength and endurance in youth, provided that the program is well designed and supervised and participants are trained in proper techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8,9,32,33\">",
"     8,9,32,33",
"    </a>",
"    ]. The program should be tailored to the individual with respect to age, size, sport, and level of experience [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8,29,34\">",
"     8,29,34",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Strength training'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H23\">",
"     'Principles of training'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Organized programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increasing number of children are participating in organized sports. The younger the participant, the greater are the concerns about safety and benefits.",
"   </p>",
"   <p>",
"    Young participants are often enticed by the success of professional athletes. The reality is very few high school senior athletes will be drafted to play professional sports [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/35\">",
"     35",
"    </a>",
"    ]. In addition, college scholarships can motivate young athletes (and parents) to commit to specialized training at an early age. Nonetheless, youth, particularly children, should be encouraged to participate in regular physical activity and exercise for the sake of enjoyment and not merely competition. Emphasis should be given to increasing habitual physical activity.",
"   </p>",
"   <p>",
"    Chronological age, physical, cognitive, and social maturity, and developmental physiology must be taken into consideration when developing and implementing physical activity and exercise programs for youth. Children have different physiologic responses to exercise than do adults and require different programs to acquire health benefits, develop fitness,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    improve performance [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/36-38\">",
"     36-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Participation need not begin with competitive sports. Participation may evolve from preparatory physical activity, recreation, or conditioning programs [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/34\">",
"     34",
"    </a>",
"    ]. It is thought that participation in strength-building activities before sports participation may prevent, reduce the risks of, or lessen the severity of sports-related injuries, but there is no conclusive evidence to support this [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33,39,40\">",
"     33,39,40",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Injury prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Goals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Safe and effective organized activities and sports for children have age- and developmentally appropriate objectives, which include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/40\">",
"     40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acquisition of basic motor skills",
"     </li>",
"     <li>",
"      Increasing physical activity levels",
"     </li>",
"     <li>",
"      Learning social skills (eg, working as a team, good sportsmanship)",
"     </li>",
"     <li>",
"      Having fun",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Participation in organized activities and sports provides an opportunity for children to learn to follow age- or skill-appropriate rules and to develop self-discipline, self-esteem, and leadership [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Organized programs also should teach youth about their bodies, promote injury prevention, and provide education about health-related topics (eg, proper nutrition, hydration, and substance abuse, such as ergogenic aids or anabolic steroids). These programs should contribute to the overall development of the child and the adoption of lifelong exercise behaviors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Components",
"    </span>",
"    &nbsp;&mdash;&nbsp;General physical conditioning should be part of every organized sports program. Physical fitness should be improved to safely and enjoyably participate in a sport. A well-designed exercise program may increase the likelihood that a child will participate in other activities and develop positive physical activity behaviors. Broadly based participation in a variety of skills and activities is related to increased participation and success in sports later in life [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A general strength-training program is beneficial as one component of an overall conditioning program, adds variety to the exercise program, and increases adherence. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Strength training'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Role of the primary care provider",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary care provider has several roles in promoting physical fitness for his or her young patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Encouraging daily physical activity in all children and youth, and, for those who are interested, promoting a well-rounded general conditioning program to improve or maintain all of the components of physical fitness",
"     </li>",
"     <li>",
"      Helping parents determine the readiness of their child to participate in organized sports or a strength-training program (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Readiness to participate'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Performing the preparticipation examination",
"     </li>",
"     <li>",
"      Identifying contraindications and limitations to participation and defining modifications to participation and training",
"     </li>",
"     <li>",
"      Providing education and anticipatory guidance regarding nutrition, hydration, ergogenic aids, or performance enhancing drugs such as anabolic steroids",
"     </li>",
"     <li>",
"      Educating families on how to select experienced and qualified fitness or strength and conditioning specialists (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Choosing a coach'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      The National Prevention Strategy recommends that clinicians conduct physical activity assessments, provide counseling, and refer patients to allied health care or health and fitness professionals [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/42\">",
"       42",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, primary care providers can work with sports administrators and coaches in the community to share relevant information on injury prevention, injury assessment, rehabilitation, first aid, safety, and guidelines for returning to full activity following an injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     STRENGTH TRAINING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Federal physical activity guidelines recommend muscle-strengthening activities on three or more days per week [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/43\">",
"     43",
"    </a>",
"    ]. According to the 2010 National Youth Physical Activity and Nutrition Survey, 51 percent of high-school students met this objective [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Well-designed and supervised youth strength-training programs that follow recommended guidelines and safety precautions are accepted as safe and effective by the American Academy of Pediatrics (AAP), American College of Sports Medicine (ACSM), American Orthopaedic Society for Sports Medicine (AOSSM), and the National Strength and Conditioning Association (NSCA) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8,32,33,44,45\">",
"     8,32,33,44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Misconceptions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parents may have questions about the timing, safety, volume, risks, and benefits of strength training for their child. Despite the acceptance of strength training among health-care and fitness professionals, there are several persistent misconceptions about its safety and benefits. These misconceptions are addressed below; they include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Strength training is unsafe and stunts growth (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Safety'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Strength training does not improve performance or reduce the risk of injury in children and adolescents (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Performance'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H15\">",
"       'Injury prevention'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Strength training does not increase strength in children because they do not have enough testosterone (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Strength'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Strength training is only for youth who compete in sports (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Other effects'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mature, responsible coaching and supervision is the key to preventing strength-training-related injuries in youth. Most physical activities have some degree of inherent risk of musculoskeletal injury. A well-supervised strength-training program poses no greater risk to youth than does participation in many other recreational activities or sports [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Strength training poses a risk of injury to the skeleton and soft tissues. The traditional concern in children is the potential for damage to the epiphyseal (growth) plate. However, an appropriate frequency of strength training using recommended loads, sets, and repetitions typically does not impose excess stress to the growth plate. Prolonged periods of repetitive impact activities such as high volumes of endurance training pose a greater risk of epiphyseal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of growth plate injury is minimal if children are taught correct principles of strength training and a gradual and appropriate progression of load is applied under the supervision of competent adults [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/32,33,49\">",
"     32,33,49",
"    </a>",
"    ]. The case reports of epiphyseal plate fractures occurring during strength training have been attributed to misuse of equipment, improper lifting technique, lifting inappropriately heavy weight, or training in unsupervised settings [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Principles of training'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Repetitive soft-tissue injuries and injuries to the lower back are additional concerns for children participating in strength training. Overuse injuries result from repetitive microtrauma to structures that do not have the strength to withstand continual or repetitive forces of activity. The prevalence of overuse injuries is difficult to determine since they may not result in emergency department or clinician visits. The likelihood of such injuries may be increased by emphasizing sport-specific skills rather than overall fitness [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/34\">",
"     34",
"    </a>",
"    ]. Injuries to the lower back are often a result of using unsafe training devices, improper lifting technique, or lifting inappropriately heavy weight.",
"   </p>",
"   <p>",
"    With appropriate supervision, strength training may have a favorable influence on bone growth and development during childhood and adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33,50\">",
"     33,50",
"    </a>",
"    ]. There is no evidence that strength training in a controlled environment affects the growth of young participants [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Strength",
"    </span>",
"    &nbsp;&mdash;&nbsp;For a strength-training program to be effective, the gain in strength must surpass that which is expected based on normal growth and maturation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/48\">",
"     48",
"    </a>",
"    ]. Such gains have been noted in children following relatively short periods (8 to 12 weeks) of a well-designed strength-training program. Strength gains of 30 to 50 percent have been reported in comparative trials [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/53-57\">",
"     53-57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children and adolescents participating in a well-designed strength-training program make similar relative gains in strength, although adolescents make greater absolute gains [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/49\">",
"     49",
"    </a>",
"    ]. The difference between the response to strength training in children and adolescents may be related to differences in circulating androgen levels, but other factors appear to contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/55,58,59\">",
"     55,58,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In adolescents &ndash; The ability of strength training to increase strength in adolescents is well established [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/60\">",
"       60",
"      </a>",
"      ]. Increases in strength in adolescents are due to the combined effects of neural adaptations and increases in muscle mass (hypertrophy) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/48,61\">",
"       48,61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In children &ndash; Three meta-analyses provide evidence that strength gains are possible in children [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/59,62,63\">",
"       59,62,63",
"      </a>",
"      ]. The benefits of strength training are not sex-specific: girls and boys both benefit from strength training. The training-induced strength gains observed in children are due to neural adaptations, rather than hypertrophy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/34,55,56,58\">",
"       34,55,56,58",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Strength training in children likely improves the coordinated recruitment of motor units, increases the number of motor units recruited,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      improves the firing rate or firing pattern of activated motor neurons [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/58\">",
"       58",
"      </a>",
"      ]. Improvements in strength also have been attributed to improved coordination [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/64\">",
"       64",
"      </a>",
"      ]. Increased neural response and improved coordination may facilitate injury prevention in other sports and activities of daily living [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/45\">",
"       45",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Injury prevention'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Although hypertrophy is not a typical response to strength training in children, there is some evidence that it may occur [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/65\">",
"       65",
"      </a>",
"      ]. Further research using longer training periods, higher training intensities, and more precise measurement techniques may be necessary to demonstrate the potential for hypertrophy in children [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Performance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall performance benefits to the participant vary depending on the quantity and quality of training, levels of competitiveness, type of sport (contact or noncontact), and the skill level of the participant.",
"   </p>",
"   <p>",
"    Performance in a specific sport is affected by many variables. It is important to distinguish between performance in a specific sport, performance on motor skill tests, and athletic ability. Improved strength does not necessarily improve performance. Following training, improvements in motor skills (eg, agility, height of vertical jump, sprint speed) may be more noticeable than improvement in performance [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/66-69\">",
"     66-69",
"    </a>",
"    ]. Greater transfer of strength and power to motor performance can be achieved by using resistance exercises that closely simulate the actions of the specific sport.",
"   </p>",
"   <p>",
"    Children and adolescents should understand that although strength training improves muscular strength and endurance, it may not improve sport-specific performance. Children and adolescents should participate in an overall conditioning program that develops all of the components of health- and sports-related physical fitness and sport-specific skills as part of an individual or team training program. An increase in physical fitness (including strength) will increase the youth's ability to participate in a variety of activities, work, play, recreation, and sports.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Injury prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of injury increases with participation in sports. There is no conclusive evidence that strength training directly reduces the prevalence or severity of injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/40\">",
"     40",
"    </a>",
"    ]. However, participation in an overall conditioning program may indirectly reduce the risk or lessen the severity of sports-related injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33,39,40,49,70,71\">",
"     33,39,40,49,70,71",
"    </a>",
"    ]. Physical conditioning, including strength training, may reduce the risk of injury during nonsport and nonleisure physical activities.",
"   </p>",
"   <p>",
"    Children and adolescents can be encouraged to participate in an overall conditioning program prior to or in the early stages of a sports program.",
"   </p>",
"   <p>",
"    An overall conditioning program that includes strength training may help to prepare unconditioned youth for the demands of sports practice and competition [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. It increases the strength of the muscles, tendons, and joints and increases joint stability. Strength training that develops strength through the full functional range of motion also maintains flexibility [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11,32,33,49\">",
"     11,32,33,49",
"    </a>",
"    ]. Each of these effects potentially contributes to a reduced risk of injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Participation in a well-supervised and structured strength-training program may have benefits beyond increased strength and performance for the athlete and nonathlete alike (",
"    <a class=\"graphic graphic_table graphicRef80712 \" href=\"UTD.htm?9/48/9995\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Participation in a conditioning program that includes strength training can help children to learn about their bodies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/47\">",
"     47",
"    </a>",
"    ]. It may change their attitudes toward physical conditioning, physical fitness, physical education, and lifelong exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/7\">",
"     7",
"    </a>",
"    ]. Strength training may be particularly beneficial for",
"    <span class=\"nowrap\">",
"     overweight/obese",
"    </span>",
"    children who may not be able to tolerate prolonged periods of aerobic exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     STRENGTH-TRAINING PROGRAMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Training guidelines and recommendations for developing and implementing strength-training programs for youth have been published in the fitness literature [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/9,33,34,47,75,76\">",
"     9,33,34,47,75,76",
"    </a>",
"    ]. Recommendations for warm-up and cool-down, overload, and progression of exercises are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef67238 \" href=\"UTD.htm?30/0/30732\">",
"     table 2",
"    </a>",
"    ) and discussed in greater detail below. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Principles of training'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     General guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of a youth strength-training program is to increase muscular strength and endurance while being exposed to a variety of fun, safe, and age- and developmentally appropriate effective training methods, sports, and activities as part of a well-rounded fitness program. The development of strength should complement, and not neglect, other components of physical fitness and well-being.",
"   </p>",
"   <p>",
"    Serious injury may occur if proper guidelines are not followed. Close attention should be given to any related pain or injury. Normal muscle soreness must be distinguishable from pain. Pain during an exercise precludes continuation of that exercise. Pain following an exercise, including the following day, precludes performing the exercise during the next exercise session [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11\">",
"     11",
"    </a>",
"    ]. Symptoms that persist longer than two days merit medical evaluation.",
"   </p>",
"   <p>",
"    Additional general guidelines for a safe and successful program include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/9,34,47,76,77\">",
"     9,34,47,76,77",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Qualified adults should provide supervision and instruction at all times. Adult spotters should actively assist the participant when necessary, in the event of a failed repetition.",
"     </li>",
"     <li>",
"      Participants should wear appropriate clothing and footwear.",
"     </li>",
"     <li>",
"      Strength-training equipment should fit the participant.",
"     </li>",
"     <li>",
"      The focus should be on safe training, proper technique (eg, controlled movements and proper breathing), and individual improvement rather than on competition and the amount of resistance.",
"     </li>",
"     <li>",
"      Progress should be monitored and reviewed regularly.",
"     </li>",
"     <li>",
"      The program should be varied over time to prevent boredom and burnout.",
"     </li>",
"     <li>",
"      To avoid injury during periods of accelerated growth (eg, the adolescent growth spurt), the intensity and total volume of the training program, the athlete's response to training, and reports of discomfort and pain should be closely monitored.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Readiness to participate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Readiness to participate in strength training is defined relative to the demands of the sport and the physical, cognitive, and social maturity of the child. Children and adolescents should begin strength training only if they perceive it to be worthwhile and should continue strength training only if it continues to be enjoyable, satisfying, meaningful, and challenging [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11\">",
"     11",
"    </a>",
"    ]. Children must clearly understand that the objectives of strength training are increased muscular strength and endurance, rather than increased muscle size.",
"   </p>",
"   <p>",
"    There is no minimal age requirement for participation in strength training, but each participant should have the maturity to accept and follow directions (usually around seven or eight years). If a child is capable of participating in an organized youth sport, he or she is capable of participating in some form of program designed to condition the body to meet the physical demands imposed by the sport [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pediatric or sports medicine clinician can help the parents determine the readiness of a child to participate in organized sports or a strength-training program. The physical, cognitive, and social demands of the activity or sport must be considered. Physical maturity is a major factor in determining a child's ability to withstand the stresses of sports participation or athletic training and conditioning [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some organizations suggest a preparticipation examination by a clinician knowledgeable in sports medicine before participation in strength training [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8,11,32\">",
"     8,11,32",
"    </a>",
"    ]. Others suggest that for apparently healthy youth, a medical examination is desirable but not absolutely necessary before participation in a strength-training program [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33\">",
"     33",
"    </a>",
"    ]. There is general agreement that preparticipation examination is mandatory for participants with known or suspected conditions that may exclude or limit participation or require treatment (eg, hypertension). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36058?source=see_link\">",
"     \"The preparticipation sports examination in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A preparticipation examination can be an important component of injury prevention, especially when undiagnosed or incompletely rehabilitated injuries are identified and treated [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/76\">",
"     76",
"    </a>",
"    ]. It also provides an opportunity for the clinician to ask about the participant's health behaviors and to educate the participant and parents (",
"    <a class=\"graphic graphic_table graphicRef73068 \" href=\"UTD.htm?41/1/42011\">",
"     table 3",
"    </a>",
"    ). The American Academy of Pediatrics (AAP) suggests that youth with uncontrolled hypertension, seizure disorders, or a history of anthracycline-based chemotherapy for childhood cancer should undergo additional evaluation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment before participation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Contraindications and precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AAP suggests that youth with cardiomyopathy (particularly hypertrophic cardiomyopathy) should be counseled against weight training since they are at risk for worsening ventricular hypertrophy and restrictive cardiomyopathy or hemodynamic decompensation secondary to an acute increase in pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8\">",
"     8",
"    </a>",
"    ]. The AAP also suggests that youth with moderate to severe pulmonary hypertension refrain from strenuous weight training because they are at risk for acute decompensation with a sudden change in hemodynamics [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Choosing a coach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Choosing a coach is an important parental responsibility [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11\">",
"     11",
"    </a>",
"    ]. Coaches and parents must have a common goal of the overall development of the child and the adoption of lifelong exercise behaviors.",
"   </p>",
"   <p>",
"    Coaches, supervisors, or trainers should have adequate education and experience to apply scientific knowledge and principles to the development and progression of a training program for a given participant. They should provide the participant instruction regarding exercise technique, use of equipment, weight-room etiquette, training guidelines, and safety. The primary focus of the program should be learning and mastering new motor skills and movements used in strength training.",
"   </p>",
"   <p>",
"    Parents can be referred to the Web sites of the American College of Sports Medicine (ACSM) (",
"    <a class=\"external\" href=\"file://www.acsm.org/\">",
"     www.acsm.org",
"    </a>",
"    ) or National Strength and Conditioning Association (NSCM) (",
"    <a class=\"external\" href=\"file://www.nsca-lift.org/\">",
"     www.nsca-lift.org",
"    </a>",
"    ) for help in finding a qualified professional to lead a strength-training program. Parents and their child should agree on the purpose of having a personal trainer, the training objectives, and the criteria for continuing to have a personal trainer. In addition, some public schools include strength training as part of their physical education curriculum or as an after-school program. Some local fitness centers or community recreation centers include strength-training programs for youth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strength-training equipment should fit the participant. Young or small children who use equipment designed for use by adults will not have proper body alignment and support, making the exercise less effective and potentially unsafe. In addition, the weight increments on many machines designed for adult use are too large for most children and adolescents. Alternative methods of applying resistance are discussed below (see",
"    <a class=\"local\" href=\"#H27\">",
"     'Overload'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Principles of training",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are eight principles of training that are applied to conditioning programs (",
"    <a class=\"graphic graphic_table graphicRef67238 \" href=\"UTD.htm?30/0/30732\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Individualization",
"     </li>",
"     <li>",
"      Warm-up and cool-down",
"     </li>",
"     <li>",
"      Specificity",
"     </li>",
"     <li>",
"      Overload",
"     </li>",
"     <li>",
"      Adaptation",
"     </li>",
"     <li>",
"      Progression",
"     </li>",
"     <li>",
"      Maintenance",
"     </li>",
"     <li>",
"      Reversal",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Individualization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each participant has unique goals, objectives, needs, abilities, limitations, resources, experience, etc, that affect his or her participation, performance, and improvement in an activity or sport. Clinicians, parents, coaches, teachers, and program directors can help each participant to safely and effectively meet his or her unique needs. To increase adherence and compliance, the child should be actively involved in the selection and development of an exercise program that meets his or her personal, physical, and social needs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Warm-up/cool-down",
"    </span>",
"    &nbsp;&mdash;&nbsp;Every bout of exercise should begin with a 5- to 10-minute active warm-up that includes stretching, aerobic exercise, and repetitions of light resistance to prepare the body for the specific activity that will be forthcoming. Warm-up activities increase body temperature and blood flow to active musculature, and stimulate metabolism.",
"   </p>",
"   <p>",
"    Each exercise session also should be followed by a 10- to 15-minute active cool-down period that includes light aerobic exercise and stretching. Cool-down activities maintain blood flow to active muscles during recovery and enhance the quality and effectiveness of the recovery period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Specificity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The training stimulus (overload) must be effectively applied to a specific physiological system for the expected neuromuscular adaptations to take place. Training adaptations are specific to the type and mode of training and the total overload. Greater transfer of training adaptations to performance is achieved when resistance exercises closely simulate the actions of the specific sport.",
"   </p>",
"   <p>",
"    A well-rounded general strength-training program can meet the needs of most youth. Such a program can increase muscular strength and endurance, speed, and power. Athletic performance, on the other hand, is optimized by matching the demands of the sport with the training program: training the appropriate metabolic systems and duplicating sport-specific joint velocities and angular movements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Overload",
"    </span>",
"    &nbsp;&mdash;&nbsp;For neuromuscular adaptation (training effect) to occur, the training stimulus must be greater than that to which the participant is normally accustomed. A strength-training overload is applied through the choice and order of exercises, load, sets, repetitions, rest periods, and frequency of training. The load can be applied through various forms of resistance (eg, free weights, machines, body weight, elastic cords, etc.). The type of load may influence the benefit of strength training. In a meta-analysis, anisometric (also called isotonic) training programs had a greater effect than isometric training programs, but the effect sizes were not statistically significantly different [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Choice and order of exercises &ndash; When choosing exercises, it is important that the child fits the equipment and that the skills and technique to perform the exercise are properly taught. Six to eight exercises that train the major muscle groups (chest, shoulders, back, arms, legs, abdomen, lower back) should be selected with appropriate balance across joints (ie, flexors and extensors), as well as between upper and lower body muscle groups.",
"      <br/>",
"      <br/>",
"      Participants should be encouraged to train all the major muscle groups, rather than a limited number (eg, chest and arms). Because of the potential for lower back injuries during strength training, exercises that strengthen the core (ie, abdomen and lower back) should be included in all training programs [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/9,11,34\">",
"       9,11,34",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Injury prevention'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Most exercises should be performed through the full natural functional range of motion to properly develop strength and prevent loss of flexibility [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11,32,33,49\">",
"       11,32,33,49",
"      </a>",
"      ]. Exceptions include exercises that place undue stress on joint capsules or have extreme ranges of motion, such as bar dips and supine dumbbell flies. These exercises should be performed only to the point of the upper arm being parallel to the ground (",
"      <a class=\"graphic graphic_picture graphicRef65981 \" href=\"UTD.htm?2/31/2546\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef61592 \" href=\"UTD.htm?24/30/25058\">",
"       picture 2",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      There is no optimal order for performing exercises. Common practice is to perform multi-joint exercises before single joint exercises, complex movements before simple movements, and large muscle groups before small muscle groups. Performing exercise in this order helps to prevent training plateaus, increase training efficiency, and decrease injury potential.",
"     </li>",
"     <li>",
"      Load &ndash; Load is the measurable amount of resistance. Load should be selected so that the predetermined number of sets and repetitions can be completed with some fatigue (not failure). Fatigue is the participant's perception that the repetitions are too hard or that form and technique cannot be maintained. Failure is the inability to complete the repetition. If the participant fails to complete at least 10 repetitions per set with a given weight, the weight is too heavy and should be reduced [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/9,11\">",
"       9,11",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      When learning new movements, no-load repetitions can be used to develop balance and control. Load can be gradually increased as the movement is learned, but increments in load should not exceed the participant's ability to maintain balance, control, and proper technique.",
"      <br/>",
"      <br/>",
"      There are various opinions on whether youth should lift maximal amounts of weight. Some organizations recommend that strength-training programs exclude lifting maximal amounts of weight for children and adolescents until they attain physical and skeletal maturity [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8,76\">",
"       8,76",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Maximal lifts can be used to evaluate the effectiveness of a strength-training program when the maximal lifts are supervised and performed correctly following an adequate progression of loading [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/80\">",
"       80",
"      </a>",
"      ]. However, there is no support for the continuous use of maximum resistance training in youth. Instead of continually lifting maximum loads, participants should be encouraged to use submaximal loads to develop form and technique in a variety of exercises.",
"      <br/>",
"      <br/>",
"      Strength-training programs for youth should not rely on only one form of resistance (eg, free weights or machines) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33,76\">",
"       33,76",
"      </a>",
"      ]. Programs should be designed to include a variety of physical activities and training methods that develop muscular strength, rather than \"specializing\" in one strength-training method. Different methods of applying a resistance, such as use of body weight, free weights, weight machines, rubber tubing, and medicine balls can be used in strength-training programs for youth.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Body weight (ie, pull-ups, bar dips, or push-ups) should not be used as a form of resistance when working with sedentary or obese children who lack the strength to safely and successfully perform the exercise.",
"     </li>",
"     <li>",
"      Free weights are a viable alternative to weight machines when child-size equipment is not available or when working with large children who have difficulty getting in and out of machines. Light-weight or unloaded bars should be used initially to develop proper technique and movement patterns.",
"     </li>",
"     <li>",
"      Rubber tubing or other forms of resistance bands can be used by many children who are not ready to use free weights or machines. Since the resistance increases further into the range of motion, children should be encouraged to move through a full range of motion while maintaining proper body alignment.",
"     </li>",
"     <li>",
"      Medicine balls of various sizes can be used to develop upper-body and abdominal strength.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sets &ndash; A set is the completion of a given number of repetitions. Single-set protocols are often completed in the first several weeks of training when skill development and conditioning is low. Most youth are encouraged to begin a strength-training program using one to two sets.",
"     </li>",
"     <li>",
"      Repetitions &ndash; Repetition is the number of times the load is lifted in a given set. Once movement patterns are established, it is recommended that youth perform sets using loads that permit 6 to 15 repetitions [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33\">",
"       33",
"      </a>",
"      ]. He or she should progress to 3 sets of 20 repetitions before the resistance is increased.",
"     </li>",
"     <li>",
"      Rest periods &ndash; A rest period is the amount of rest between sets or between exercise sessions. The length of rest periods between sets contributes to the overall overload since shorter rest periods decrease the recovery of energy producing metabolic pathways and affect performance on subsequent sets.",
"      <br/>",
"      <br/>",
"      One to three minutes of rest between sets is generally adequate; shorter rest periods are used to emphasize hypertrophy and longer rest periods to maximize strength. Most youth have difficulty resting more than one to two minutes between sets.",
"     </li>",
"     <li>",
"      Frequency of training &ndash; Muscle groups should be given at least 24 hours of rest between exercise sessions. Thus, strength training in youth should be limited to two to three nonconsecutive days per week. Older adolescents who are highly motivated can strength-train four days per week, provided that they alternate muscle groups. In a meta-analysis of resistance training in children and adolescents, increased frequency of training was associated with increased strength gains [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Adaptation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adaptation is the primary reason for engaging in any activity, exercise, or conditioning program. The neuromuscular adaptations of strength training in youth include increased numbers and coordination of recruited motor units and improved firing rate or firing pattern of activated motor neurons [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Strength'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition, regular physical activity, including a well-designed strength-training program, helps to optimize development of bone mass. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40040?source=see_link&amp;anchor=H15#H15\">",
"     \"Calcium requirements in adolescents\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Progression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The progression of an exercise program is critical to safely and effectively meet the individual's goals and objectives. As strength increases, the original absolute resistance represents a lower workload relative to capacity. The overload must be modified to provide an effective stimulus for adaptation to continue.",
"   </p>",
"   <p>",
"    The overload can be changed by increasing the resistance, the number of exercises performed for each muscle group, sets, repetitions, or frequency of training.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Before increasing the number of sets or resistance, participants should be able to demonstrate proper technique.",
"     </li>",
"     <li>",
"      Resistance can be increased when the desired number of repetitions can be performed, when 20 repetitions becomes \"easy\", or when the participant can complete three sets of 20 repetitions [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11,34\">",
"       11,34",
"      </a>",
"      ]. Resistance can be increased in increments of 5 to 10 percent.",
"     </li>",
"     <li>",
"      The addition of exercises for each muscle group adds variety to a program, emphasizes the overall objective of conditioning, and introduces new movement patterns and motor skills. Addition of new exercises should include the use of single-joint and multijoint exercises. Multiple-joint exercises are beneficial for the development of neuromuscular coordination and skill technique and require more balance and stabilization [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. Participants should not be allowed to perform more complex exercises until less complex exercises are mastered [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11,33\">",
"       11,33",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Progression to performing two to three exercises per muscle group for one to three sets of 10 to 15 repetitions, performed three days per week, or three to four sets of six to eight repetitions, has been recommended [",
"      <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/11,34,49\">",
"       11,34,49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Maintenance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The maintenance phase is the longest portion of any conditioning program. Eventually, the participant is satisfied with the adaptations, training effect, and new level of physical fitness, health, or performance, and increases in overload (progression) are no longer needed. Less total overload is necessary to maintain adaptations than to achieve the desired outcome. Duration of training can influence the benefit of strength training, since training interventions of longer duration are more beneficial than similar training programs of shorter duration [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Reversal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Youth participation in sports and conditioning programs is often spontaneous and sporadic. It is likely, therefore, that many youth will undergo periods of reduced training and activity. Following a reduction or withdrawal of strength training, strength and other adaptations regress to pretraining levels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/56,81\">",
"     56,81",
"    </a>",
"    ]. This phenomenon is often referred to as \"detraining\" and occurs in children as well as adults.",
"   </p>",
"   <p>",
"    In children, the effects of detraining are confounded by the concomitant growth-related increases in strength. The precise nature of the detraining response in children and adolescents remains uncertain. However, changes in neuromuscular function probably play a significant role in the observed changes in strength or motor performance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Olympic-style lifting",
"    </span>",
"    &nbsp;&mdash;&nbsp;The snatch and the clean-and-jerk are the two lifts included in the sport of weight lifting. In the snatch, a barbell is lifted from the ground to an arm's-length position overhead in one continuous movement. In the clean-and-jerk, the barbell is lifted from the ground to the shoulder and then to an arm&rsquo;s length position overhead in a two-part movement. Both lifts are performed rapidly and require a great deal of technique.",
"   </p>",
"   <p>",
"    Olympic-style weight lifting movements can be used as an effective training modality to improve strength, power, and coordination [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/34,82-85\">",
"     34,82-85",
"    </a>",
"    ]. The American Academy of Pediatrics suggests that children and adolescents avoid competitive weight lifting and power lifting until they reach physical and skeletal maturity [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/8\">",
"     8",
"    </a>",
"    ]. Others suggest that such lifts are appropriate for youth who demonstrate the maturity and desire to learn proper technique before using significant amounts of weight [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/34,82,84,86\">",
"     34,82,84,86",
"    </a>",
"    ]. The amount of time and effort required to learn and practice technique may vary between participants.",
"   </p>",
"   <p>",
"    With proper training and technique, weight lifting is safer than many other sports in which teenagers regularly participate [",
"    <a class=\"abstract\" href=\"UTD.htm?13/61/14298/abstract/82,84\">",
"     82,84",
"    </a>",
"    ]. The forces to which children are exposed in other sports and activities are often greater in duration and magnitude and typically occur in uncontrolled settings. The snatch and the clean-and-jerk are complex movements and require knowledgeable coaching and supervision. When technical mastery is emphasized, there is a decreased risk of injury.",
"   </p>",
"   <p>",
"    Olympic-style lifts should not be attempted without proper training and supervision; this point cannot be overemphasized. The training program should include other lifts and forms of conditioning to provide overall training. The technique for the snatch and clean-and-jerk should be learned using a wooden pole, polyvinylchloride (PVC) pipe, or light weight-training bar. Resistance should not be increased until the child has developed the necessary neuromuscular coordination and skill to perform the lift correctly. Light to moderate intensities (less than 75 percent of the one repetition maximum) are recommended for youth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children should be encouraged to participate in regular physical activity in order to establish good health habits at an early age. A panel convened by the United States Centers for Disease Control and Prevention recommends that school-age children participate in at least 60 minutes per day of moderate to vigorous physical activity. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Physical activity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Organized physical activity and sports programs should contribute to the overall development of the child and the adoption of lifelong exercise behaviors. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Goals'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Well-designed and supervised strength-training programs that follow recommended guidelines and precautions are safe and effective in producing strength gains (and other benefits) for children and adolescents (both boys and girls). Strength training programs for children and adolescents should be a part of an overall well-rounded fitness program that complements other components of physical fitness and well-being. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Strength-training programs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Readiness to participate in strength training is defined relative to the demands of the sport and the physical, cognitive, and social maturity of the child. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Readiness to participate'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children and adolescents who participate in strength-training programs should follow the guiding principles outlined in the table (",
"      <a class=\"graphic graphic_table graphicRef67238 \" href=\"UTD.htm?30/0/30732\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Principles of training'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/1\">",
"      Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273:402.",
"     </a>",
"    </li>",
"    <li>",
"     Healthy People 2020. Physical Activity and Fitness. file://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=33 (Accessed on August 04, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/3\">",
"      Strong WB, Malina RM, Blimkie CJ, et al. Evidence based physical activity for school-age youth. J Pediatr 2005; 146:732.",
"     </a>",
"    </li>",
"    <li>",
"     How much physical activity do children need? Centers for Disease Control and Prevention 2008. www.cdc.gov/physicalactivity/everyone/guidelines/children.html (Accessed on July 28, 2009).",
"    </li>",
"    <li>",
"     Chapter 3: Active Children and Adolescents. 2008 Physical Activity Guidelines for Americans. U.S. Department of Health and Human Services. file://www.health.gov/PAGuidelines/guidelines/chapter3.aspx (Accessed on July 28, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/6\">",
"      Guidelines for school and community programs to promote lifelong physical activity among young people. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997; 46:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/7\">",
"      McKeag DB. Adolescents and exercise. J Adolesc Health Care 1986; 7:121S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/8\">",
"      American Academy of Pediatrics Council on Sports Medicine and Fitness, McCambridge TM, Stricker PR. Strength training by children and adolescents. Pediatrics 2008; 121:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/9\">",
"      Benjamin HJ, Glow KM. Strength training for children and adolescents: what can physicians recommend? Phys Sportsmed 2003; 31:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/10\">",
"      Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985; 100:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/11\">",
"      Webb DR. Strength training in children and adolescents. Pediatr Clin North Am 1990; 37:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/12\">",
"      Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39:1423.",
"     </a>",
"    </li>",
"    <li>",
"     How much physical activity do adults need? Centers for Disease Control and Prevention 2008. www.cdc.gov/physicalactivity/everyone/guidelines/adults.html (Accessed on July 28, 2009).",
"    </li>",
"    <li>",
"     Chapter 4: Active Adults. 2008 Physical Activity Guidelines for Americans. U.S. Department of Health and Human Services 2008. www.health.gov/PAGuidelines/guidelines/chapter4.aspx (Accessed on July 28, 2009).",
"    </li>",
"    <li>",
"     2008 Physical Activity Guidelines for Americans. U.S. Department of Health &amp; Human Services. www.health.gov/PAGuidelines/ (Accessed on October 08, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/16\">",
"      Nader PR, Bradley RH, Houts RM, et al. Moderate-to-vigorous physical activity from ages 9 to 15 years. JAMA 2008; 300:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/17\">",
"      Correction. Incorrect data in: Moderate-to-vigorous physical activity from ages 9 to 15 years. JAMA 2009; 301:2095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/18\">",
"      Centers for Disease Control and Prevention (CDC). Physical activity levels of high school students --- United States, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/19\">",
"      Baranowski T, Cullen KW, Basen-Engquist K, et al. Transitions out of high school: time of increased cancer risk? Prev Med 1997; 26:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/20\">",
"      Tell GS, Vellar OD. Physical fitness, physical activity, and cardiovascular disease risk factors in adolescents: the Oslo Youth Study. Prev Med 1988; 17:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/21\">",
"      Sallis JF, McKenzie TL, Alcaraz JE. Habitual physical activity and health-related physical fitness in fourth-grade children. Am J Dis Child 1993; 147:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/22\">",
"      Rubin K, Schirduan V, Gendreau P, et al. Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. J Pediatr 1993; 123:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/23\">",
"      Janz KF, Gilmore JM, Burns TL, et al. Physical activity augments bone mineral accrual in young children: The Iowa Bone Development study. J Pediatr 2006; 148:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/24\">",
"      Gutin B, Basch C, Shea S, et al. Blood pressure, fitness, and fatness in 5- and 6-year-old children. JAMA 1990; 264:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/25\">",
"      Hansen HS, Froberg K, Hyldebrandt N, Nielsen JR. A controlled study of eight months of physical training and reduction of blood pressure in children: the Odense schoolchild study. BMJ 1991; 303:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/26\">",
"      Shea S, Basch CE, Gutin B, et al. The rate of increase in blood pressure in children 5 years of age is related to changes in aerobic fitness and body mass index. Pediatrics 1994; 94:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/27\">",
"      Sung RY, Yu CW, Chang SK, et al. Effects of dietary intervention and strength training on blood lipid level in obese children. Arch Dis Child 2002; 86:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/28\">",
"      Sardinha LB, Baptista F, Ekelund U. Objectively measured physical activity and bone strength in 9-year-old boys and girls. Pediatrics 2008; 122:e728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/29\">",
"      Faigenbaum AD, Zaichjiwsky LD. Psychological effects of strength training on children. J Sport Behav 1990; 20:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/30\">",
"      Calfas KJ, Taylor WC. Effects of physical activity on psychological variables in adolescents. Pediatr Exerc Sci 1994; 6:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/31\">",
"      Singh A, Uijtdewilligen L, Twisk JW, et al. Physical activity and performance at school: a systematic review of the literature including a methodological quality assessment. Arch Pediatr Adolesc Med 2012; 166:49.",
"     </a>",
"    </li>",
"    <li>",
"     Cahill BR. American Orthopaedic Society for Sports Medicine: Proceedings of the Conference on Strength Training and the Prepubescent., American Orthopaedic Society for Sports Medicine, Chicago 1988. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/33\">",
"      Faigenbaum AD, Kraemer WJ, Blimkie CJ, et al. Youth resistance training: updated position statement paper from the national strength and conditioning association. J Strength Cond Res 2009; 23:S60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/34\">",
"      Faigenbaum AD. Strength training for children and adolescents. Clin Sports Med 2000; 19:593.",
"     </a>",
"    </li>",
"    <li>",
"     National Collegiate Athletic Association. Estimated probability of competing in athletics beyond the high school interscholastic level. file://www.ncaa.org/wps/portal/ncaahome?WCM_GLOBAL_CONTEXT=/ncaa/NCAA/Academics+and+Athletes/Education+and+Research/Probability+of+Competing/Methodology+-+Prob+of+Competing (Accessed on August 04, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/36\">",
"      Plowman SA. Children aren't miniature adults: Similarities and differences in physiological responses to exercise, Part 2. ACSM's Health and Fitness Journal 2001; 5:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/37\">",
"      Plowman SA. Children aren't miniature adults: Similarities and differences in physiological responses to exercise, Part 1. ACSM's Health and Fitness Journal 2001; 5:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/38\">",
"      Faigenbaum AD. FUNdamental fitness in children: recommendations for keeping kids healthy and fit. ACSM's Health and Fitness Journal 1998; 2:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/39\">",
"      Current comment from the American College of Sports Medicine. August 1993--\"The prevention of sport injuries of children and adolescents\". Med Sci Sports Exerc 1993; 25:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/40\">",
"      Washington RL, Bernhardt DT, Gomez J, et al. Organized sports for children and preadolescents. Pediatrics 2001; 107:1459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/41\">",
"      Intensive training and sports specialization in young athletes. American Academy of Pediatrics. Committee on Sports Medicine and Fitness. Pediatrics 2000; 106:154.",
"     </a>",
"    </li>",
"    <li>",
"     National Prevention Council. National Prevention Strategy. America's plan for better health and wellness. file://www.healthcare.gov/center/councils/nphpphc/strategy/report.pdf (Accessed on July 14, 2011).",
"    </li>",
"    <li>",
"     2008 Physical Activity Guidelines for Americans. file://www.health.gov/paguidelines/guidelines/default.aspx (Accessed on June 29, 2011).",
"    </li>",
"    <li>",
"     Faigenbaum AD. Youth resistance training (presented as part of the NSCA Hot Topic Series). file://www.nsca-lift.org/HotTopic/download/Youth Hot Topics.pdf (Accessed on August 04, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/45\">",
"      Schafer JP. Prepubescent and adolescent weight training: Is it safe? Is it beneficial. J Strength Cond Res 1991; 13:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/46\">",
"      Vehrs PR. Strength training for children and teens: Dispelling misconceptions - Part One. ACSM's Health and Fitness Journal 2005; 9:8.",
"     </a>",
"    </li>",
"    <li>",
"     Faigenbaum, AD. Youth resistance training. (presented as part of the NSCA Hot Topic Series). file://www.nsca-lift.org/HotTopic/download/Youth Hot Topics.pdf (Accessed on August 04, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/48\">",
"      Guy JA, Micheli LJ. Strength training for children and adolescents. J Am Acad Orthop Surg 2001; 9:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/49\">",
"      Blimkie CJ. Resistance training during preadolescence. Issues and controversies. Sports Med 1993; 15:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/50\">",
"      Vicente-Rodr&iacute;guez G. How does exercise affect bone development during growth? Sports Med 2006; 36:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/51\">",
"      Falk B, Eliakim A. Resistance training, skeletal muscle and growth. Pediatr Endocrinol Rev 2003; 1:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/52\">",
"      Bailey DA, Martin AD. Physical activity and skeletal health in adolescents. Pediatr Exerc Sci 1994; 6:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/53\">",
"      Sewall L, Micheli LJ. Strength training for children. J Pediatr Orthop 1986; 6:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/54\">",
"      Faigenbaum AD, Westcott WL, Loud RL, Long C. The effects of different resistance training protocols on muscular strength and endurance development in children. Pediatrics 1999; 104:e5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/55\">",
"      Ramsay JA, Blimkie CJ, Smith K, et al. Strength training effects in prepubescent boys. Med Sci Sports Exerc 1990; 22:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/56\">",
"      Blimkie CJ. Resistance training during pre- and early puberty: efficacy, trainability, mechanisms, and persistence. Can J Sport Sci 1992; 17:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/57\">",
"      Faigenbaum AD, Milliken LA, Loud RL, et al. Comparison of 1 and 2 days per week of strength training in children. Res Q Exerc Sport 2002; 73:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/58\">",
"      Ozmun JC, Mikesky AE, Surburg PR. Neuromuscular adaptations following prepubescent strength training. Med Sci Sports Exerc 1994; 26:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/59\">",
"      Behringer M, Vom Heede A, Yue Z, Mester J. Effects of resistance training in children and adolescents: a meta-analysis. Pediatrics 2010; 126:e1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/60\">",
"      GALLAGHER JR, DeLORME TL. The use of the technique of progressive-resistance exercise in adolescence. J Bone Joint Surg Am 1949; 31A:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/61\">",
"      Purcell JS, Hergenroeder AC. Physical conditioning in adolescents. Curr Opin Pediatr 1994; 6:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/62\">",
"      Falk B, Tenenbaum G. The effectiveness of resistance training in children. A meta-analysis. Sports Med 1996; 22:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/63\">",
"      Payne VG, Morrow JR Jr, Johnson L, Dalton SN. Resistance training in children and youth: a meta-analysis. Res Q Exerc Sport 1997; 68:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/64\">",
"      Borms J. The child and exercise: an overview. J Sports Sci 1986; 4:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/65\">",
"      Fukunaga T, Funato K, Ikegawa S. The effects of resistance training on muscle area and strength in prepubescent age. Ann Physiol Anthropol 1992; 11:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/66\">",
"      Falk B, Mor G. The effects of resistance and martial arts training in 6 to 8 year old boys. Pediatr Exerc Sci 1996; 8:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/67\">",
"      Hetzer R, DeRenne C, Buxton B, et al. Effects of 12 weeks of strength training on aerobic power in prepubescent male athletes. J Strength Cond Res 1997; 11:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/68\">",
"      Lillegard WA, Brown EW, Wilson DJ, et al. Efficacy of strength training in prepubescent to early postpubescent males and females: effects of gender and maturity. Pediatr Rehabil 1997; 1:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/69\">",
"      Weltman A, Janney C, Rians CB, et al. The effects of hydraulic resistance strength training in pre-pubertal males. Med Sci Sports Exerc 1986; 18:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/70\">",
"      Cahill BR, Griffith EH. Effect of preseason conditioning on the incidence and severity of high school football knee injuries. Am J Sports Med 1978; 6:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/71\">",
"      Heidt RS Jr, Sweeterman LM, Carlonas RL, et al. Avoidance of soccer injuries with preseason conditioning. Am J Sports Med 2000; 28:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/72\">",
"      Micheli LJ, Glassman R, Klein M. The prevention of sports injuries in children. Clin Sports Med 2000; 19:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/73\">",
"      Outerbridge AR, Micheli LJ. Overuse injuries in the young athlete. Clin Sports Med 1995; 14:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/74\">",
"      Watts K, Jones TW, Davis EA, Green D. Exercise training in obese children and adolescents: current concepts. Sports Med 2005; 35:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/75\">",
"      Vehrs PR. Strength training for children and teens: Implementing effective programs - Part two. ACSM's Health and Fitness Journal 2005; 9:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/76\">",
"      Current comment from the American College of Sports Medicine. August 1993--\"The prevention of sport injuries of children and adolescents\". Med Sci Sports Exerc 1993; 25:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/77\">",
"      Brenner JS, American Academy of Pediatrics Council on Sports Medicine and Fitness. Overuse injuries, overtraining, and burnout in child and adolescent athletes. Pediatrics 2007; 119:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/78\">",
"      Dalton SE. Overuse injuries in adolescent athletes. Sports Med 1992; 13:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/79\">",
"      Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004; 109:2807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/80\">",
"      Faigenbaum AD, Milliken LA, Westcott WL. Maximal strength testing in healthy children. J Strength Cond Res 2003; 17:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/81\">",
"      Faigenbaum AD, Wescott WL, Micheli L, et al. The effects of strength training and detraining on children. J Strength Cond Res 1996; 10:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/82\">",
"      Faigenbaum AD, Polakowski C. Olympic style weightlifting: Kid style. Strength Cond J 1999; 21:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/83\">",
"      Byrd R, Pierce K, Rielly L, Brady J. Young weightlifters' performance across time. Sports Biomech 2003; 2:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/84\">",
"      Hamill BP. Relative safety of weight lifting and weight training. J Strength Cond Res 1994; 8:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/85\">",
"      Servedio FJ, Bartels RL, Hamlin RL, et al. The effects of weight training, using Olympic style lifts, on various physiological variables in prepubescent boys. Med Sci Sports Exerc 1985; 17:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/61/14298/abstract/86\">",
"      Pierce K, Byrd R, Stone M. Injuries in youth weightlifting. J Strength Cond Res 1999; 13:430.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6474 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14298=[""].join("\n");
var outline_f13_61_14298=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHYSICAL ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Amount",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Benefits of activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Organized programs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Goals",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Components",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Role of the primary care provider",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      STRENGTH TRAINING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Misconceptions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Safety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Strength",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Performance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Injury prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      STRENGTH-TRAINING PROGRAMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      General guidelines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Readiness to participate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Contraindications and precautions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Choosing a coach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Principles of training",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Individualization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Warm-up/cool-down",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Specificity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Overload",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Adaptation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Progression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Maintenance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Reversal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Olympic-style lifting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6474\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6474|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/31/2546\" title=\"picture 1\">",
"      Bar dips",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/30/25058\" title=\"picture 2\">",
"      Supine dumbell flies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6474|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/48/9995\" title=\"table 1\">",
"      Benefits strength training",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/0/30732\" title=\"table 2\">",
"      Strength training guideline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/1/42011\" title=\"table 3\">",
"      Presports exam counseling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40040?source=related_link\">",
"      Calcium requirements in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=related_link\">",
"      Overview of the benefits and risks of exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36058?source=related_link\">",
"      The preparticipation sports examination in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_61_14299="Major causes of right axis deviation";
var content_f13_61_14299=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71386&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71386&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of right axis deviation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Artifactual",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Left-right arm electrode reversal (look for negative P and negative QRS in lead I)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal variant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Right ventricular overload",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Acute - pulmonary embolus or other causes of acute cor pulmonale",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Chronic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Chronic obstructive lung disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Any cause of right ventricular hypertrophy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lateral wall myocardial infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dextrocardia, as with situs inversus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Left posterior fascicular block - must exclude other causes listed above",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14299=[""].join("\n");
var outline_f13_61_14299=null;
var title_f13_61_14300="Phases of tonic clonic seizures";
var content_f13_61_14300=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Phases of tonic-clonic seizures",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Aura (None)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Tonic phase (10 to 20 seconds)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sudden loss of consciousness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loss of posture with high risk of self injury depending on activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brief flexion of arms, eyes deviated upward",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extension of back, neck, arms, and legs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Involuntary crying out from contraction of respiratory muscles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shallow respiration, cyanosis may occur",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ends with tremors which gradually slow and merge with clonic phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Clonic phase (30 to 90 seconds)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brief, violent, generalized flexor contractions alternating with progressively longer muscle relaxation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyanosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Possible cheek or tongue biting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Foamy salivation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Possible loss of bowel or bladder control",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ends with deep inspiration, sustained muscle relaxation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Postictal phase (Minutes to several hours)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Headache, mild confusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Muscles sore",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fatigue, patient may sleep and awake refreshed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fast heart rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory and metabolic acidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dilated pupils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Risk of vertebral fracture, pneumonia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14300=[""].join("\n");
var outline_f13_61_14300=null;
var title_f13_61_14301="Reversible cause incontinence A";
var content_f13_61_14301=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F82618%7EPC%2F60839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F82618%7EPC%2F60839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Identification of reversible conditions that cause or contribute to urinary incontinence",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Affecting the lower urinary tract",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urinary tract infection (symptomatic with frequency, urgency, dysuria, etc)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Atrophic vaginitis/urethritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pregnancy/vaginal delivery/ episiotomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Postprostatectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Stool impaction",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\">",
"        Increased urine production",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Metabolic (hyperglycemia, hypercalcemia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Excess fluid intake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Volume overload:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Venous insufficiency with edema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Heart failure",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\">",
"        Impaired ability or willingness to reach a toilet",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Delirium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chronic illness, injury or restraint that interferes with mobility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Psychological",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\">",
"        Nocturia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nocturnal polyuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sleep disturbance",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Identification and management of reversible conditions that cause or contribute to urinary incontinence: part B",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Condition",
"      </td>",
"      <td class=\"subtitle1\">",
"       Management",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Increased urine production",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Metabolic (hyperglycemia, hypercalcemia)",
"      </td>",
"      <td>",
"       Improved control of diabetes mellitus or treatment of hypercalcemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Excess fluid intake",
"      </td>",
"      <td>",
"       Reduction in intake of excess fluids, especially diuretic fluids (eg, caffeinated beverages, including soda, alcohol)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\" colspan=\"2\" rowspan=\"1\">",
"       Volume overload:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Venous insufficiency with edema",
"      </td>",
"      <td class=\"sublist_other\">",
"       Support stockings; leg elevation; sodium restriction; diuretic therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Heart failure",
"      </td>",
"      <td class=\"sublist_other\">",
"       Medical therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Impaired ability or willingness to reach a toilet",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Delirium",
"      </td>",
"      <td>",
"       Diagnosis and treatment of underlying causes of acute confusional state",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Chronic illness, injury or restraint that interferes with mobility",
"      </td>",
"      <td>",
"       Address cause of impaired mobility, remove restrains if possible. Regular toileting; use of toilet substitutes and environmental alterations (eg, bedside commode, urinal)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Psychological",
"      </td>",
"      <td>",
"       Appropriate pharmacologic and/or nonpharmacologic treatment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Nocturia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Nocturnal polyuria",
"      </td>",
"      <td>",
"       Assess evening fluid intake, assess for volume overload, consider sleep apnea if other symptoms, signs, or risk factors present",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Sleep disturbance",
"      </td>",
"      <td>",
"       Sleep hygiene; assess for pain, depression, and environmental causes; consider sleep apnea if other symptoms, signs, or risk factors present",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14301=[""].join("\n");
var outline_f13_61_14301=null;
var title_f13_61_14302="Stool on virtual colonoscopy";
var content_f13_61_14302=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stool on virtual colonoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 244px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Virtual colonoscopy of the ascending colon shows stool adherent to the wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14302=[""].join("\n");
var outline_f13_61_14302=null;
var title_f13_61_14303="Choledocholithiasis after OLT";
var content_f13_61_14303=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66728&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Common bile duct obstruction due to stones following liver transplantation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 276px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic retrograde cholangiopancreatographic image shows stones and sludge (arrows) which have developed in the donor common bile duct (CBD) following liver transplantation. The patient presented with jaundice and was successfully treated with balloon dilation of the bile duct anastomosis and extraction of the stones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_61_14303=[""].join("\n");
var outline_f13_61_14303=null;
